Genes for Enhancing Nitrogen Utilization Efficiency in Crop Plants

ABSTRACT

The invention provides isolated NUE (nitrogen utilization efficiency) nucleic acids and their encoded proteins. The present invention provides methods and compositions relating to altering nitrogen utilization and/or uptake in plants. The invention further provides recombinant expression cassettes, host cells and transgenic plants.

CROSS REFERENCE

This utility application claims the benefit of co-pending U.S. patentapplication Ser. No. 14/017,677 filed Sep. 9, 2014 which claims benefitof U.S. patent application Ser. No. 13/551,020 filed Jul. 12, 2012 whichclaims benefit of U.S. patent application Ser. No. 12/881,254 filed onSep. 14, 2010, now U.S. Pat. No. 8,247,650 which issued on Aug. 21,2012, which claims benefit of U.S. patent application Ser. No.12/506,459 filed on Jul. 21, 2009, which claims benefit of U.S. patentapplication Ser. No. 11/668,514 filed on Jan. 30, 2007, now U.S. Pat.No. 7,589,257 which issued on Sep. 15, 2009, which claims benefit ofU.S. Provisional Application Ser. No. 60/771,906, filed Feb. 9, 2006,all of which are incorporated herein by reference.

FIELD OF THE INVENTION

The invention relates generally to the field of molecular biology.

BACKGROUND OF THE INVENTION

The domestication of many plants has correlated with dramatic increasesin yield. Most phenotypic variation occurring in natural populations iscontinuous and is effected by multiple gene influences. Theidentification of specific genes responsible for the dramaticdifferences in yield, in domesticated plants, has become an importantfocus of agricultural research.

One group of genes effecting yield are the nitrogen utilizationefficiency (NUE) genes. These genes have utility for improving the useof nitrogen in crop plants, especially maize. The genes can be used toalter the genetic composition of the plants rendering them moreproductive with current fertilizer application standards or maintainingtheir productive rates with significantly reduced fertilizer input.Increased nitrogen use efficiency can result from enhanced uptake andassimilation of nitrogen fertilizer and/or the subsequent remobilizationand reutilization of accumulated nitrogen reserves. Plants containingthese genes can therefore be used for the enhancement of yield.Improving the nitrogen use efficiency in corn would increase cornharvestable yield per unit of input nitrogen fertilizer, both indeveloping nations where access to nitrogen fertilizer is limited and indeveloped nations were the level of nitrogen use remains high. Nitrogenutilization improvement also allows decreases in on-farm input costs,decreased use and dependence on the non-renewable energy sourcesrequired for nitrogen fertilizer production and decreases theenvironmental impact of nitrogen fertilizer manufacturing andagricultural use.

SUMMARY OF THE INVENTION

The present invention provides polynucleotides, related polypeptides andall conservatively modified variants of the present NUE sequences. Theinvention provides sequences for the NUE genes.

The present invention presents methods to alter the genetic compositionof crop plants, especially maize, so that such crops can be moreproductive with current fertilizer applications and/or as productivewith significantly reduced fertilizer input. The utility of this classof invention is then both yield enhancement and reduced fertilizer costswith corresponding reduced impact to the environment. The geneticenhancement of the crop plant's intrinsic genetics in order to enhancenitrogen use efficiency has not been achieved by scientists in the pastin any commercially viable sense. This invention uniquely uses a highlyselected set of maize plants that has been shown to differ in aspects ofnitrogen utilization. The plants were then subjected to experiments inmRNA profiling and data analysis to yield a set of genes that are usefulfor modification of crop plants, especially maize for enhancing nitrogenuse efficiency.

Therefore, in one aspect, the present invention relates to an isolatednucleic acid comprising an isolated polynucleotide sequence encoding anNUE gene. One embodiment of the invention is an isolated polynucleotidecomprising a nucleotide sequence selected from the group consisting of:(a) the nucleotide sequence comprising SEQ ID NO: 1, 3, 5, 7, 9, 11, 13,15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49,51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85,87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113, 115, 117,119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141, 143, 145,147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169, 171, 173,175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197, 199, 201,203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 223, 225, 227, 229,231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, 255, 257,259, 261, 263, 265, 267, 269, 271, 273, 275, 277, 279, 281, 283, 285,287, 289, 291, 293, 295, 297, 299, 301, 303, 305, 307, 309, 311 or 313;(b) the nucleotide sequence encoding an amino acid sequence comprisingSEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32,34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68,70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102,104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130,132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154, 156, 158,160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182, 184, 186,188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210, 212, 214,216, 218, 220, 222, 224, 226, 228, 230, 232, 234, 236, 238, 240, 242,244, 246, 248, 250, 252, 254, 256, 258, 260, 262, 264, 266, 268, 270,272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298,300, 302, 304, 306, 308, 310, 312 or 314 and (c) the nucleotide sequencecomprising at least 70% sequence identity to SEQ ID NO: 1, 3, 5, 7, 9,11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45,47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81,83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109, 111, 113,115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137, 139, 141,143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169,171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195, 197,199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221, 223, 225,227, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253,255, 257, 259, 261, 263, 265, 267, 269, 271, 273, 275, 277, 279, 281,283, 285, 287, 289, 291, 293, 295, 297, 299, 301, 303, 305, 307, 309,311 or 313, wherein said polynucleotide encodes a polypeptide havingenhanced nitrogen utilization efficiency activity.

Compositions of the invention include an isolated polypeptide comprisingan amino acid sequence selected from the group consisting of: (a) theamino acid sequence comprising SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16,18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52,54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88,90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118,120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140, 142, 144, 146,148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170, 172, 174,176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196, 198, 200, 202,204, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 226, 228, 230,232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252, 254, 256, 258,260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280, 282, 284, 286,288, 290, 292, 294, 296, 298, 300, 302, 304, 306, 308, 310, 312 or 314and (b) the amino acid sequence comprising at least 70% sequenceidentity to SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26,28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62,64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98,100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126,128, 130, 132, 134, 136, 138, 140, 142, 144, 146, 148, 150, 152, 154,156, 158, 160, 162, 164, 166, 168, 170, 172, 174, 176, 178, 180, 182,184, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 206, 208, 210,212, 214, 216, 218, 220, 222, 224, 226, 228, 230, 232, 234, 236, 238,240, 242, 244, 246, 248, 250, 252, 254, 256, 258, 260, 262, 264, 266,268, 270, 272, 274, 276, 278, 280, 282, 284, 286, 288, 290, 292, 294,296, 298, 300, 302, 304, 306, 308, 310, 312 or 314, wherein saidpolypeptide has enhanced nitrogen utilization efficiency activity.

In another aspect, the present invention relates to a recombinantexpression cassette comprising a nucleic acid as described.Additionally, the present invention relates to a vector containing therecombinant expression cassette. Further, the vector containing therecombinant expression cassette can facilitate the transcription andtranslation of the nucleic acid in a host cell. The present inventionalso relates to the host cells able to express the polynucleotide of thepresent invention. A number of host cells could be used, such as but notlimited to, microbial, mammalian, plant or insect.

In yet another embodiment, the present invention is directed to atransgenic plant or plant cells, containing the nucleic acids of thepresent invention. Preferred plants containing the polynucleotides ofthe present invention include, but are not limited to, maize, soybean,sunflower, sorghum, canola, wheat, alfalfa, cotton, rice, barley, tomatoand millet. In another embodiment, the transgenic plant is a maize plantor plant cells. Another embodiment is the transgenic seeds from thetransgenic NUE polypeptide of the invention operably linked to apromoter that drives expression in the plant. The plants of theinvention can have altered NUE as compared to a control plant. In someplants, the NUE is altered in a vegetative tissue, a reproductive tissueor a vegetative tissue and a reproductive tissue. Plants of theinvention can have at least one of the following phenotypes including,but not limited to: increased root mass, increased root length,increased leaf size, increased ear size, increased seed size, increasedendosperm size, alterations in the relative size of embryos andendosperms leading to changes in the relative levels of protein, oiland/or starch in the seeds, absence of tassels, absence of functionalpollen bearing tassels or increased plant size.

Another embodiment of the invention would be plants that have beengenetically modified at a genomic locus, wherein the genomic locusencodes a NUE polypeptide of the invention.

Methods for increasing the activity of NUE polypeptide in a plant areprovided. The method can comprise introducing into the plant an NUEpolynucleotide of the invention.

Methods for reducing or eliminating the level of NUE polypeptide in theplant are provided. The level or activity of the polypeptide could alsobe reduced or eliminated in specific tissues, causing alteration inplant growth rate. Reducing the level and/or activity of the NUEpolypeptide may lead to smaller stature or slower growth of plants.

DETAILED DESCRIPTION OF THE INVENTION

Unless defined otherwise, all technical and scientific terms used hereinhave the same meaning as commonly understood by one of ordinary skill inthe art to which this invention belongs. Unless mentioned otherwise, thetechniques employed or contemplated herein are standard methodologieswell known to one of ordinary skill in the art. The materials, methodsand examples are illustrative only and not limiting. The following ispresented by way of illustration and is not intended to limit the scopeof the invention.

The present inventions now will be described more fully hereinafter withreference to the accompanying drawings, in which some, but not allembodiments of the invention are shown. Indeed, these inventions may beembodied in many different forms and should not be construed as limitedto the embodiments set forth herein; rather, these embodiments areprovided so that this disclosure will satisfy applicable legalrequirements. Like numbers refer to like elements throughout.

Many modifications and other embodiments of the inventions set forthherein will come to mind to one skilled in the art to which theseinventions pertain having the benefit of the teachings presented in theforegoing descriptions and the associated drawings. Therefore, it is tobe understood that the inventions are not to be limited to the specificembodiments disclosed and that modifications and other embodiments areintended to be included within the scope of the appended claims.Although specific terms are employed herein, they are used in a genericand descriptive sense only and not for purposes of limitation.

The practice of the present invention will employ, unless otherwiseindicated, conventional techniques of botany, microbiology, tissueculture, molecular biology, chemistry, biochemistry and recombinant DNAtechnology, which are within the skill of the art. Such techniques areexplained fully in the literature. See, e.g., Langenheim and Thimann,(1982) Botany: Plant Biology and Its Relation to Human Affairs, JohnWiley; Cell Culture and Somatic Cell Genetics of Plants, vol. 1, Vasil,ed. (1984); Stanier, et al., (1986) The Microbial World, 5th ed.,Prentice-Hall; Dhringra and Sinclair, (1985) Basic Plant PathologyMethods, CRC Press; Maniatis, et al., (1982) Molecular Cloning: ALaboratory Manual; DNA Cloning, vols. I and II, Glover, ed. (1985);Oligonucleotide Synthesis, Gait, ed. (1984); Nucleic Acid Hybridization,Hames and Higgins, eds. (1984); and the series Methods in Enzymology,Colowick and Kaplan, eds, Academic Press, Inc., San Diego, Calif.

Units, prefixes and symbols may be denoted in their SI accepted form.Unless otherwise indicated, nucleic acids are written left to right in5′ to 3′ orientation; amino acid sequences are written left to right inamino to carboxy orientation, respectively. Numeric ranges are inclusiveof the numbers defining the range. Amino acids may be referred to hereinby either their commonly known three letter symbols or by the one-lettersymbols recommended by the IUPAC-IUB Biochemical NomenclatureCommission. Nucleotides, likewise, may be referred to by their commonlyaccepted single-letter codes. The terms defined below are more fullydefined by reference to the specification as a whole.

In describing the present invention, the following terms will beemployed and are intended to be defined as indicated below.

By “microbe” is meant any microorganism (including both eukaryotic andprokaryotic microorganisms), such as fungi, yeast, bacteria,actinomycetes, algae and protozoa, as well as other unicellularstructures.

By “amplified” is meant the construction of multiple copies of a nucleicacid sequence or multiple copies complementary to the nucleic acidsequence using at least one of the nucleic acid sequences as a template.Amplification systems include the polymerase chain reaction (PCR)system, ligase chain reaction (LCR) system, nucleic acid sequence basedamplification (NASBA, Cangene, Mississauga, Ontario), O-Beta Replicasesystems, transcription-based amplification system (TAS) and stranddisplacement amplification (SDA). See, e.g., Diagnostic MolecularMicrobiology Principles and Applications, Persing, et al., eds.,American Society for Microbiology, Washington, D.C. (1993). The productof amplification is termed an amplicon.

The term “conservatively modified variants” applies to both amino acidand nucleic acid sequences. With respect to particular nucleic acidsequences, conservatively modified variants refer to those nucleic acidsthat encode identical or conservatively modified variants of the aminoacid sequences. Because of the degeneracy of the genetic code, a largenumber of functionally identical nucleic acids encode any given protein.For instance, the codons GCA, GCC, GCG and GCU all encode the amino acidalanine. Thus, at every position where an alanine is specified by acodon, the codon can be altered to any of the corresponding codonsdescribed without altering the encoded polypeptide. Such nucleic acidvariations are “silent variations” and represent one species ofconservatively modified variation. Every nucleic acid sequence hereinthat encodes a polypeptide also describes every possible silentvariation of the nucleic acid. One of ordinary skill will recognize thateach codon in a nucleic acid (except AUG, which is ordinarily the onlycodon for methionine; one exception is Micrococcus rubens, for which GTGis the methionine codon (Ishizuka, et al., (1993) J. Gen. Microbiol.139:425-32) can be modified to yield a functionally identical molecule.Accordingly, each silent variation of a nucleic acid, which encodes apolypeptide of the present invention, is implicit in each describedpolypeptide sequence and incorporated herein by reference.

As to amino acid sequences, one of skill will recognize that individualsubstitutions, deletions or additions to a nucleic acid, peptide,polypeptide or protein sequence which alters, adds or deletes a singleamino acid or a small percentage of amino acids in the encoded sequenceis a “conservatively modified variant” when the alteration results inthe substitution of an amino acid with a chemically similar amino acid.Thus, any number of amino acid residues selected from the group ofintegers consisting of from 1 to 15 can be so altered. Thus, forexample, 1, 2, 3, 4, 5, 7 or 10 alterations can be made. Conservativelymodified variants typically provide similar biological activity as theunmodified polypeptide sequence from which they are derived. Forexample, substrate specificity, enzyme activity or ligand/receptorbinding is generally at least 30%, 40%, 50%, 60%, 70%, 80% or 90%,preferably 60-90% of the native protein for it's native substrate.Conservative substitution tables providing functionally similar aminoacids are well known in the art.

The following six groups each contain amino acids that are conservativesubstitutions for one another:

-   -   1) Alanine (A), Serine (S), Threonine (T);    -   2) Aspartic acid (D), Glutamic acid (E);    -   3) Asparagine (N), Glutamine (Q);    -   4) Arginine (R), Lysine (K);    -   5) Isoleucine (I), Leucine (L), Methionine (M), Valine (V) and    -   6) Phenylalanine (F), Tyrosine (Y), Tryptophan (W).        See also, Creighton, Proteins, W.H. Freeman and Co. (1984).

As used herein, “consisting essentially of” means the inclusion ofadditional sequences to an object polynucleotide where the additionalsequences do not selectively hybridize, under stringent hybridizationconditions, to the same cDNA as the polynucleotide and where thehybridization conditions include a wash step in 0.1×SSC and 0.1% sodiumdodecyl sulfate at 65° C.

By “encoding” or “encoded,” with respect to a specified nucleic acid, ismeant comprising the information for translation into the specifiedprotein. A nucleic acid encoding a protein may comprise non-translatedsequences (e.g., introns) within translated regions of the nucleic acidor may lack such intervening non-translated sequences (e.g., as incDNA). The information by which a protein is encoded is specified by theuse of codons. Typically, the amino acid sequence is encoded by thenucleic acid using the “universal” genetic code. However, variants ofthe universal code, such as is present in some plant, animal and fungalmitochondria, the bacterium Mycoplasma capricolumn (Yamao, et al.,(1985) Proc. Natl. Acad. Sci. USA 82:2306-9) or the ciliateMacronucleus, may be used when the nucleic acid is expressed using theseorganisms.

When the nucleic acid is prepared or altered synthetically, advantagecan be taken of known codon preferences of the intended host where thenucleic acid is to be expressed. For example, although nucleic acidsequences of the present invention may be expressed in bothmonocotyledonous and dicotyledonous plant species, sequences can bemodified to account for the specific codon preferences and GC contentpreferences of monocotyledonous plants or dicotyledonous plants as thesepreferences have been shown to differ (Murray, et al., (1989) NucleicAcids Res. 17:477-98 and herein incorporated by reference). Thus, themaize preferred codon for a particular amino acid might be derived fromknown gene sequences from maize. Maize codon usage for 28 genes frommaize plants is listed in Table 4 of Murray, et al., supra.

As used herein, “heterologous” in reference to a nucleic acid is anucleic acid that originates from a foreign species, or, if from thesame species, is substantially modified from its native form incomposition and/or genomic locus by deliberate human intervention. Forexample, a promoter operably linked to a heterologous structural gene isfrom a species different from that from which the structural gene wasderived or, if from the same species, one or both are substantiallymodified from their original form. A heterologous protein may originatefrom a foreign species or, if from the same species, is substantiallymodified from its original form by deliberate human intervention.

By “host cell” is meant a cell, which comprises a heterologous nucleicacid sequence of the invention, which contains a vector and supports thereplication and/or expression of the expression vector. Host cells maybe prokaryotic cells such as E. coli, or eukaryotic cells such as yeast,insect, plant, amphibian or mammalian cells. Preferably, host cells aremonocotyledonous or dicotyledonous plant cells, including but notlimited to maize, sorghum, sunflower, soybean, wheat, alfalfa, rice,cotton, canola, barley, millet and tomato. A particularly preferredmonocotyledonous host cell is a maize host cell.

The term “hybridization complex” includes reference to a duplex nucleicacid structure formed by two single-stranded nucleic acid sequencesselectively hybridized with each other.

The term “introduced” in the context of inserting a nucleic acid into acell, means “transfection” or “transformation” or “transduction” andincludes reference to the incorporation of a nucleic acid into aeukaryotic or prokaryotic cell where the nucleic acid may beincorporated into the genome of the cell (e.g., chromosome, plasmid,plastid or mitochondrial DNA), converted into an autonomous replicon ortransiently expressed (e.g., transfected mRNA).

The terms “isolated” refers to material, such as a nucleic acid or aprotein, which is substantially or essentially free from componentswhich normally accompany or interact with it as found in its naturallyoccurring environment. The isolated material optionally comprisesmaterial not found with the material in its natural environment. Nucleicacids, which are “isolated”, as defined herein, are also referred to as“heterologous” nucleic acids. Unless otherwise stated, the term “NUEnucleic acid” means a nucleic acid comprising a polynucleotide (“NUEpolynucleotide”) encoding a full length or partial length NUEpolypeptide.

As used herein, “nucleic acid” includes reference to adeoxyribonucleotide or ribonucleotide polymer in either single- ordouble-stranded form, and unless otherwise limited, encompasses knownanalogues having the essential nature of natural nucleotides in thatthey hybridize to single-stranded nucleic acids in a manner similar tonaturally occurring nucleotides (e.g., peptide nucleic acids).

By “nucleic acid library” is meant a collection of isolated DNA or RNAmolecules, which comprise and substantially represent the entiretranscribed fraction of a genome of a specified organism. Constructionof exemplary nucleic acid libraries, such as genomic and cDNA libraries,is taught in standard molecular biology references such as Berger andKimmel, (1987) Guide To Molecular Cloning Techniques, from the seriesMethods in Enzymology, vol. 152, Academic Press, Inc., San Diego,Calif.; Sambrook, et al., (1989) Molecular Cloning: A Laboratory Manual,2^(nd) ed., vols. 1-3; and Current Protocols in Molecular Biology,Ausubel, et al., eds, Current Protocols, a joint venture between GreenePublishing Associates, Inc. and John Wiley & Sons, Inc. (1994Supplement).

As used herein “operably linked” includes reference to a functionallinkage between a first sequence, such as a promoter and a secondsequence, wherein the promoter sequence initiates and mediatestranscription of the DNA corresponding to the second sequence.Generally, operably linked means that the nucleic acid sequences beinglinked are contiguous and, where necessary to join two protein codingregions, contiguous and in the same reading frame.

As used herein, the term “plant” includes reference to whole plants,plant organs (e.g., leaves, stems, roots, etc.), seeds and plant cellsand progeny of same. Plant cell, as used herein includes, withoutlimitation, seeds, suspension cultures, embryos, meristematic regions,callus tissue, leaves, roots, shoots, gametophytes, sporophytes, pollenand microspores. The class of plants, which can be used in the methodsof the invention, is generally as broad as the class of higher plantsamenable to transformation techniques, including both monocotyledonousand dicotyledonous plants including species from the genera: Cucurbita,Rosa, Vitis, Juglans, Fragaria, Lotus, Medicago, Onobrychis, Trifolium,Trigonella, Vigna, Citrus, Linum, Geranium, Manihot, Daucus,Arabidopsis, Brassica, Raphanus, Sinapis, Atropa, Capsicum, Datura,Hyoscyamus, Lycopersicon, Nicotiana, Solanum, Petunia, Digitalis,Majorana, Ciahorium, Helianthus, Lactuca, Bromus, Asparagus,Antirrhinum, Heterocallis, Nemesis, Pelargonium, Panieum, Pennisetum,Ranunculus, Senecio, Salpiglossis, Cucumis, Browaalia, Glycine, Pisum,Phaseolus, Lolium, Oryza, Avena, Hordeum, Secale, Allium and Triticum. Aparticularly preferred plant is Zea mays.

As used herein, “yield” may include reference to bushels per acre of agrain crop at harvest, as adjusted for grain moisture (15% typically formaize, for example), and the volume of biomass generated (for foragecrops such as alfalfa and plant root size for multiple crops). Grainmoisture is measured in the grain at harvest. The adjusted test weightof grain is determined to be the weight in pounds per bushel, adjustedfor grain moisture level at harvest. Biomass is measured as the weightof harvestable plant material generated.

As used herein, “polynucleotide” includes reference to adeoxyribopolynucleotide, ribopolynucleotide or analogs thereof that havethe essential nature of a natural ribonucleotide in that they hybridize,under stringent hybridization conditions, to substantially the samenucleotide sequence as naturally occurring nucleotides and/or allowtranslation into the same amino acid(s) as the naturally occurringnucleotide(s). A polynucleotide can be full-length or a subsequence of anative or heterologous structural or regulatory gene. Unless otherwiseindicated, the term includes reference to the specified sequence as wellas the complementary sequence thereof. Thus, DNAs or RNAs with backbonesmodified for stability or for other reasons are “polynucleotides” asthat term is intended herein. Moreover, DNAs or RNAs comprising unusualbases, such as inosine or modified bases, such as tritylated bases, toname just two examples, are polynucleotides as the term is used herein.It will be appreciated that a great variety of modifications have beenmade to DNA and RNA that serve many useful purposes known to those ofskill in the art. The term polynucleotide as it is employed hereinembraces such chemically, enzymatically or metabolically modified formsof polynucleotides, as well as the chemical forms of DNA and RNAcharacteristic of viruses and cells, including inter alia, simple andcomplex cells.

The terms “polypeptide,” “peptide” and “protein” are usedinterchangeably herein to refer to a polymer of amino acid residues. Theterms apply to amino acid polymers in which one or more amino acidresidue is an artificial chemical analogue of a corresponding naturallyoccurring amino acid, as well as to naturally occurring amino acidpolymers.

As used herein “promoter” includes reference to a region of DNA upstreamfrom the start of transcription and involved in recognition and bindingof RNA polymerase and other proteins to initiate transcription. A “plantpromoter” is a promoter capable of initiating transcription in plantcells. Exemplary plant promoters include, but are not limited to, thosethat are obtained from plants, plant viruses and bacteria which comprisegenes expressed in plant cells such Agrobacterium or Rhizobium. Examplesare promoters that preferentially initiate transcription in certaintissues, such as leaves, roots, seeds, fibres, xylem vessels, tracheidsor sclerenchyma. Such promoters are referred to as “tissue preferred.” A“cell type” specific promoter primarily drives expression in certaincell types in one or more organs, for example, vascular cells in rootsor leaves. An “inducible” or “regulatable” promoter is a promoter, whichis under environmental control. Examples of environmental conditionsthat may effect transcription by inducible promoters include anaerobicconditions or the presence of light. Another type of promoter is adevelopmentally regulated promoter, for example, a promoter that drivesexpression during pollen development. Tissue preferred, cell typespecific, developmentally regulated and inducible promoters constitutethe class of “non-constitutive” promoters. A “constitutive” promoter isa promoter, which is active under most environmental conditions.

The term “NUE polypeptide” refers to one or more amino acid sequences.The term is also inclusive of fragments, variants, homologs, alleles orprecursors (e.g., preproproteins or proproteins) thereof. A “NUEprotein” comprises a NUE polypeptide. Unless otherwise stated, the term“NUE nucleic acid” means a nucleic acid comprising a polynucleotide(“NUE polynucleotide”) encoding a NUE polypeptide.

As used herein “recombinant” includes reference to a cell or vector,that has been modified by the introduction of a heterologous nucleicacid or that the cell is derived from a cell so modified. Thus, forexample, recombinant cells express genes that are not found in identicalform within the native (non-recombinant) form of the cell or expressnative genes that are otherwise abnormally expressed, under expressed ornot expressed at all as a result of deliberate human intervention or mayhave reduced or eliminated expression of a native gene. The term“recombinant” as used herein does not encompass the alteration of thecell or vector by naturally occurring events (e.g., spontaneousmutation, natural transformation/transduction/transposition) such asthose occurring without deliberate human intervention.

As used herein, a “recombinant expression cassette” is a nucleic acidconstruct, generated recombinantly or synthetically, with a series ofspecified nucleic acid elements, which permit transcription of aparticular nucleic acid in a target cell. The recombinant expressioncassette can be incorporated into a plasmid, chromosome, mitochondrialDNA, plastid DNA, virus or nucleic acid fragment. Typically, therecombinant expression cassette portion of an expression vectorincludes, among other sequences, a nucleic acid to be transcribed and apromoter.

The terms “residue” or “amino acid residue” or “amino acid” are usedinterchangeably herein to refer to an amino acid that is incorporatedinto a protein, polypeptide or peptide (collectively “protein”). Theamino acid may be a naturally occurring amino acid and, unless otherwiselimited, may encompass known analogs of natural amino acids that canfunction in a similar manner as naturally occurring amino acids.

The term “selectively hybridizes” includes reference to hybridization,under stringent hybridization conditions, of a nucleic acid sequence toa specified nucleic acid target sequence to a detectably greater degree(e.g., at least 2-fold over background) than its hybridization tonon-target nucleic acid sequences and to the substantial exclusion ofnon-target nucleic acids. Selectively hybridizing sequences typicallyhave about at least 40% sequence identity, preferably 60-90% sequenceidentity and most preferably 100% sequence identity (i.e.,complementary) with each other.

The terms “stringent conditions” or “stringent hybridization conditions”include reference to conditions under which a probe will hybridize toits target sequence, to a detectably greater degree than other sequences(e.g., at least 2-fold over background). Stringent conditions aresequence-dependent and will be different in different circumstances. Bycontrolling the stringency of the hybridization and/or washingconditions, target sequences can be identified which can be up to 100%complementary to the probe (homologous probing). Alternatively,stringency conditions can be adjusted to allow some mismatching insequences so that lower degrees of similarity are detected (heterologousprobing). Optimally, the probe is approximately 500 nucleotides inlength, but can vary greatly in length from less than 500 nucleotides toequal to the entire length of the target sequence.

Typically, stringent conditions will be those in which the saltconcentration is less than about 1.5 M Na ion, typically about 0.01 to1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3 and thetemperature is at least about 30° C. for short probes (e.g., 10 to 50nucleotides) and at least about 60° C. for long probes (e.g., greaterthan 50 nucleotides). Stringent conditions may also be achieved with theaddition of destabilizing agents such as formamide or Denhardt's.Exemplary low stringency conditions include hybridization with a buffersolution of 30 to 35% formamide, 1 M NaCl, 1% SDS (sodium dodecylsulphate) at 37° C. and a wash in 1× to 2×SSC (20×SSC=3.0 M NaCl/0.3 Mtrisodium citrate) at 50 to 55° C. Exemplary moderate stringencyconditions include hybridization in 40 to 45% formamide, 1 M NaCl, 1%SDS at 37° C. and a wash in 0.5× to 1×SSC at 55 to 60° C. Exemplary highstringency conditions include hybridization in 50% formamide, 1 M NaCl,1% SDS at 37° C. and a wash in 0.1×SSC at 60 to 65° C. Specificity istypically the function of post-hybridization washes, the criticalfactors being the ionic strength and temperature of the final washsolution. For DNA-DNA hybrids, the T_(m) can be approximated from theequation of Meinkoth and Wahl, (1984) Anal. Biochem., 138:267-84:T_(m)=81.5° C.+16.6 (log M)+0.41 (% GC)−0.61 (% form)−500/L; where M isthe molarity of monovalent cations, % GC is the percentage of guanosineand cytosine nucleotides in the DNA, % form is the percentage offormamide in the hybridization solution, and L is the length of thehybrid in base pairs. The T_(m) is the temperature (under defined ionicstrength and pH) at which 50% of a complementary target sequencehybridizes to a perfectly matched probe. T_(m) is reduced by about 1° C.for each 1% of mismatching; thus, T_(m), hybridization and/or washconditions can be adjusted to hybridize to sequences of the desiredidentity. For example, if sequences with ≧90% identity are sought, theT_(m) can be decreased 10° C. Generally, stringent conditions areselected to be about 5° C. lower than the thermal melting point (T_(m))for the specific sequence and its complement at a defined ionic strengthand pH. However, severely stringent conditions can utilize ahybridization and/or wash at 1, 2, 3 or 4° C. lower than the thermalmelting point (T_(m)); moderately stringent conditions can utilize ahybridization and/or wash at 6, 7, 8, 9 or 10° C. lower than the thermalmelting point (T_(m)); low stringency conditions can utilize ahybridization and/or wash at 11, 12, 13, 14, 15 or 20° C. lower than thethermal melting point (T_(m)). Using the equation, hybridization andwash compositions, and desired T_(m), those of ordinary skill willunderstand that variations in the stringency of hybridization and/orwash solutions are inherently described. If the desired degree ofmismatching results in a T_(m) of less than 45° C. (aqueous solution) or32° C. (formamide solution) it is preferred to increase the SSCconcentration so that a higher temperature can be used. An extensiveguide to the hybridization of nucleic acids is found in Tijssen,Laboratory Techniques in Biochemistry and MolecularBiology—Hybridization with Nucleic Acid Probes, part I, chapter 2,“Overview of principles of hybridization and the strategy of nucleicacid probe assays,” Elsevier, New York (1993); and Current Protocols inMolecular Biology, chapter 2, Ausubel, et al., eds, Greene Publishingand Wiley-Interscience, New York (1995). Unless otherwise stated, in thepresent application high stringency is defined as hybridization in4×SSC, 5×Denhardt's (5 g Ficoll, 5 g polyvinypyrrolidone, 5 g bovineserum albumin in 500 ml of water), 0.1 mg/ml boiled salmon sperm DNA,and 25 mM Na phosphate at 65° C. and a wash in 0.1×SSC, 0.1% SDS at 65°C.

As used herein, “transgenic plant” includes reference to a plant, whichcomprises within its genome a heterologous polynucleotide. Generally,the heterologous polynucleotide is stably integrated within the genomesuch that the polynucleotide is passed on to successive generations. Theheterologous polynucleotide may be integrated into the genome alone oras part of a recombinant expression cassette. “Transgenic” is usedherein to include any cell, cell line, callus, tissue, plant part orplant, the genotype of which has been altered by the presence ofheterologous nucleic acid including those transgenics initially soaltered as well as those created by sexual crosses or asexualpropagation from the initial transgenic. The term “transgenic” as usedherein does not encompass the alteration of the genome (chromosomal orextra-chromosomal) by conventional plant breeding methods or bynaturally occurring events such as random cross-fertilization,non-recombinant viral infection, non-recombinant bacterialtransformation, non-recombinant transposition or spontaneous mutation.

As used herein, “vector” includes reference to a nucleic acid used intransfection of a host cell and into which can be inserted apolynucleotide. Vectors are often replicons. Expression vectors permittranscription of a nucleic acid inserted therein.

The following terms are used to describe the sequence relationshipsbetween two or more nucleic acids or polynucleotides or polypeptides:(a) “reference sequence,” (b) “comparison window,” (c) “sequenceidentity,” (d) “percentage of sequence identity” and (e) “substantialidentity.”

As used herein, “reference sequence” is a defined sequence used as abasis for sequence comparison. A reference sequence may be a subset orthe entirety of a specified sequence; for example, as a segment of afull-length cDNA or gene sequence or the complete cDNA or gene sequence.

As used herein, “comparison window” means includes reference to acontiguous and specified segment of a polynucleotide sequence, whereinthe polynucleotide sequence may be compared to a reference sequence andwherein the portion of the polynucleotide sequence in the comparisonwindow may comprise additions or deletions (i.e., gaps) compared to thereference sequence (which does not comprise additions or deletions) foroptimal alignment of the two sequences. Generally, the comparison windowis at least 20 contiguous nucleotides in length, and optionally can be30, 40, 50, 100 or longer. Those of skill in the art understand that toavoid a high similarity to a reference sequence due to inclusion of gapsin the polynucleotide sequence a gap penalty is typically introduced andis subtracted from the number of matches.

Methods of alignment of nucleotide and amino acid sequences forcomparison are well known in the art. The local homology algorithm(BESTFIT) of Smith and Waterman, (1981) Adv. Appl. Math 2:482, mayconduct optimal alignment of sequences for comparison; by the homologyalignment algorithm (GAP) of Needleman and Wunsch, (1970) J. Mol. Biol.48:443-53; by the search for similarity method (Tfasta and Fasta) ofPearson and Lipman, (1988) Proc. Natl. Acad. Sci. USA 85:2444; bycomputerized implementations of these algorithms, including, but notlimited to: CLUSTAL in the PC/Gene program by Intelligenetics, MountainView, Calif., GAP, BESTFIT, BLAST, FASTA and TFASTA in the WisconsinGenetics Software Package, Version 8 (available from Genetics ComputerGroup (GCG® programs (Accelrys, Inc., San Diego, Calif.).). The CLUSTALprogram is well described by Higgins and Sharp, (1988) Gene 73:237-44;Higgins and Sharp, (1989) CABIOS 5:151-3; Corpet, et al., (1988) NucleicAcids Res. 16:10881-90; Huang, et al., (1992) Computer Applications inthe Biosciences 8:155-65 and Pearson, et al., (1994) Meth. Mol. Biol.24:307-31. The preferred program to use for optimal global alignment ofmultiple sequences is PileUp (Feng and Doolittle, (1987) J. Mol. Evol.,25:351-60 which is similar to the method described by Higgins and Sharp,(1989) CABIOS 5:151-53 and hereby incorporated by reference). The BLASTfamily of programs which can be used for database similarity searchesincludes: BLASTN for nucleotide query sequences against nucleotidedatabase sequences; BLASTX for nucleotide query sequences againstprotein database sequences; BLASTP for protein query sequences againstprotein database sequences; TBLASTN for protein query sequences againstnucleotide database sequences; and TBLASTX for nucleotide querysequences against nucleotide database sequences. See, Current Protocolsin Molecular Biology, Chapter 19, Ausubel et al., eds., GreenePublishing and Wiley-Interscience, New York (1995).

GAP uses the algorithm of Needleman and Wunsch, supra, to find thealignment of two complete sequences that maximizes the number of matchesand minimizes the number of gaps. GAP considers all possible alignmentsand gap positions and creates the alignment with the largest number ofmatched bases and the fewest gaps. It allows for the provision of a gapcreation penalty and a gap extension penalty in units of matched bases.GAP must make a profit of gap creation penalty number of matches foreach gap it inserts. If a gap extension penalty greater than zero ischosen, GAP must, in addition, make a profit for each gap inserted ofthe length of the gap times the gap extension penalty. Default gapcreation penalty values and gap extension penalty values in Version 10of the Wisconsin Genetics Software Package are 8 and 2, respectively.The gap creation and gap extension penalties can be expressed as aninteger selected from the group of integers consisting of from 0 to 100.Thus, for example, the gap creation and gap extension penalties can be0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 30, 40, 50 or greater.

GAP presents one member of the family of best alignments. There may bemany members of this family, but no other member has a better quality.GAP displays four figures of merit for alignments: Quality, Ratio,Identity and Similarity. The Quality is the metric maximized in order toalign the sequences. Ratio is the quality divided by the number of basesin the shorter segment. Percent Identity is the percent of the symbolsthat actually match. Percent Similarity is the percent of the symbolsthat are similar. Symbols that are across from gaps are ignored. Asimilarity is scored when the scoring matrix value for a pair of symbolsis greater than or equal to 0.50, the similarity threshold. The scoringmatrix used in Version 10 of the Wisconsin Genetics Software Package isBLOSUM62 (see, Henikoff and Henikoff, (1989) Proc. Natl. Acad. Sci. USA89:10915).

Unless otherwise stated, sequence identity/similarity values providedherein refer to the value obtained using the BLAST 2.0 suite of programsusing default parameters (Altschul, et al., (1997) Nucleic Acids Res.25:3389-402).

As those of ordinary skill in the art will understand, BLAST searchesassume that proteins can be modeled as random sequences. However, manyreal proteins comprise regions of nonrandom sequences, which may behomopolymeric tracts, short-period repeats, or regions enriched in oneor more amino acids. Such low-complexity regions may be aligned betweenunrelated proteins even though other regions of the protein are entirelydissimilar. A number of low-complexity filter programs can be employedto reduce such low-complexity alignments. For example, the SEG (Wootenand Federhen, (1993) Comput. Chem. 17:149-63) and XNU (Claverie andStates, (1993) Comput. Chem. 17:191-201) low-complexity filters can beemployed alone or in combination.

As used herein, “sequence identity” or “identity” in the context of twonucleic acid or polypeptide sequences includes reference to the residuesin the two sequences, which are the same when aligned for maximumcorrespondence over a specified comparison window. When percentage ofsequence identity is used in reference to proteins it is recognized thatresidue positions which are not identical often differ by conservativeamino acid substitutions, where amino acid residues are substituted forother amino acid residues with similar chemical properties (e.g., chargeor hydrophobicity) and therefore do not change the functional propertiesof the molecule. Where sequences differ in conservative substitutions,the percent sequence identity may be adjusted upwards to correct for theconservative nature of the substitution. Sequences, which differ by suchconservative substitutions, are said to have “sequence similarity” or“similarity.” Means for making this adjustment are well known to thoseof skill in the art. Typically this involves scoring a conservativesubstitution as a partial rather than a full mismatch, therebyincreasing the percentage sequence identity. Thus, for example, where anidentical amino acid is given a score of 1 and a non-conservativesubstitution is given a score of zero, a conservative substitution isgiven a score between zero and 1. The scoring of conservativesubstitutions is calculated, e.g., according to the algorithm of Meyersand Miller, (1988) Computer Applic. Biol. Sci. 4:11-17, e.g., asimplemented in the program PC/GENE (Intelligenetics, Mountain View,Calif., USA).

As used herein, “percentage of sequence identity” means the valuedetermined by comparing two optimally aligned sequences over acomparison window, wherein the portion of the polynucleotide sequence inthe comparison window may comprise additions or deletions (i.e., gaps)as compared to the reference sequence (which does not comprise additionsor deletions) for optimal alignment of the two sequences. The percentageis calculated by determining the number of positions at which theidentical nucleic acid base or amino acid residue occurs in bothsequences to yield the number of matched positions, dividing the numberof matched positions by the total number of positions in the window ofcomparison and multiplying the result by 100 to yield the percentage ofsequence identity.

The term “substantial identity” of polynucleotide sequences means that apolynucleotide comprises a sequence that has between 50-100% sequenceidentity, preferably at least 50% sequence identity, preferably at least60% sequence identity, preferably at least 70%, more preferably at least80%, more preferably at least 90% and most preferably at least 95%,compared to a reference sequence using one of the alignment programsdescribed using standard parameters. One of skill will recognize thatthese values can be appropriately adjusted to determine correspondingidentity of proteins encoded by two nucleotide sequences by taking intoaccount codon degeneracy, amino acid similarity, reading framepositioning and the like. Substantial identity of amino acid sequencesfor these purposes normally means sequence identity of between 55-100%,preferably at least 55%, preferably at least 60%, more preferably atleast 70%, 80%, 90% and most preferably at least 95%.

Another indication that nucleotide sequences are substantially identicalis if two molecules hybridize to each other under stringent conditions.The degeneracy of the genetic code allows for many amino acidssubstitutions that lead to variety in the nucleotide sequence that codefor the same amino acid, hence it is possible that the DNA sequencecould code for the same polypeptide but not hybridize to each otherunder stringent conditions. This may occur, e.g., when a copy of anucleic acid is created using the maximum codon degeneracy permitted bythe genetic code. One indication that two nucleic acid sequences aresubstantially identical is that the polypeptide, which the first nucleicacid encodes, is immunologically cross reactive with the polypeptideencoded by the second nucleic acid.

The terms “substantial identity” in the context of a peptide indicatesthat a peptide comprises a sequence with between 55-100% sequenceidentity to a reference sequence preferably at least 55% sequenceidentity, preferably 60% preferably 70%, more preferably 80%, mostpreferably at least 90% or 95% sequence identity to the referencesequence over a specified comparison window. Preferably, optimalalignment is conducted using the homology alignment algorithm ofNeedleman and Wunsch, supra. An indication that two peptide sequencesare substantially identical is that one peptide is immunologicallyreactive with antibodies raised against the second peptide. Thus, apeptide is substantially identical to a second peptide, for example,where the two peptides differ only by a conservative substitution. Inaddition, a peptide can be substantially identical to a second peptidewhen they differ by a non-conservative change if the epitope that theantibody recognizes is substantially identical. Peptides, which are“substantially similar” share sequences as, noted above except thatresidue positions, which are not identical, may differ by conservativeamino acid changes.

The invention discloses NUE polynucleotides and polypeptides. The novelnucleotides and proteins of the invention have an expression patternwhich indicates that they enhance nitrogen utilization and thus play animportant role in plant development. The polynucleotides are expressedin various plant tissues. The polynucleotides and polypeptides thusprovide an opportunity to manipulate plant development to alter tissuedevelopment, timing or composition. This may be used to create a plantwith enhanced yield under limited nitrogen supply.

Nucleic Acids

The present invention provides, inter alia, isolated nucleic acids ofRNA, DNA and analogs and/or chimeras thereof, comprising a NUEpolynucleotide.

The present invention also includes polynucleotides optimized forexpression in different organisms. For example, for expression of thepolynucleotide in a maize plant, the sequence can be altered to accountfor specific codon preferences and to alter GC content as according toMurray, et al, supra. Maize codon usage for 28 genes from maize plantsis listed in Table 4 of Murray, et al., supra.

The NUE nucleic acids of the present invention comprise isolated NUEpolynucleotides which are inclusive of:

-   -   (a) a polynucleotide encoding a NUE polypeptide and        conservatively modified and polymorphic variants thereof;    -   (b) a polynucleotide having at least 70% sequence identity with        polynucleotides of (a) or (b);    -   (c) complementary sequences of polynucleotides of (a) or (b).

Construction of Nucleic Acids

The isolated nucleic acids of the present invention can be made using(a) standard recombinant methods, (b) synthetic techniques orcombinations thereof. In some embodiments, the polynucleotides of thepresent invention will be cloned, amplified or otherwise constructedfrom a fungus or bacteria.

The nucleic acids may conveniently comprise sequences in addition to apolynucleotide of the present invention. For example, a multi-cloningsite comprising one or more endonuclease restriction sites may beinserted into the nucleic acid to aid in isolation of thepolynucleotide. Also, translatable sequences may be inserted to aid inthe isolation of the translated polynucleotide of the present invention.For example, a hexa-histidine marker sequence provides a convenientmeans to purify the proteins of the present invention. The nucleic acidof the present invention—excluding the polynucleotide sequence—isoptionally a vector, adapter or linker for cloning and/or expression ofa polynucleotide of the present invention. Additional sequences may beadded to such cloning and/or expression sequences to optimize theirfunction in cloning and/or expression, to aid in isolation of thepolynucleotide or to improve the introduction of the polynucleotide intoa cell. Typically, the length of a nucleic acid of the present inventionless the length of its polynucleotide of the present invention is lessthan 20 kilobase pairs, often less than 15 kb and frequently less than10 kb. Use of cloning vectors, expression vectors, adapters and linkersis well known in the art. Exemplary nucleic acids include such vectorsas: M13, lambda ZAP Express, lambda ZAP II, lambda gt10, lambda gt11,pBK-CMV, pBK-RSV, pBluescript II, lambda DASH II, lambda EMBL 3, lambdaEMBL 4, pWE15, SuperCos 1, SurfZap, Uni-ZAP, pBC, pBS+/−, pSG5, pBK,pCR-Script, pET, pSPUTK, p3′SS, pGEM, pSK+/−, pGEX, pSPORTI and II,pOPRSVI CAT, pOPI3 CAT, pXT1, pSG5, pPbac, pMbac, pMC1neo, pOG44, pOG45,pFRTβGAL, pNEOβGAL, pRS403, pRS404, pRS405, pRS406, pRS413, pRS414,pRS415, pRS416, lambda MOSSlox and lambda MOSElox. Optional vectors forthe present invention include, but are not limited to, lambda ZAP II andpGEX. For a description of various nucleic acids see, e.g., StratageneCloning Systems, Catalogs 1995, 1996, 1997 (La Jolla, Calif.) andAmersham Life Sciences, Inc, Catalog '97 (Arlington Heights, Ill.).

Synthetic Methods for Constructing Nucleic Acids

The isolated nucleic acids of the present invention can also be preparedby direct chemical synthesis by methods such as the phosphotriestermethod of Narang, et al., (1979) Meth. Enzymol. 68:90-9; thephosphodiester method of Brown, et al., (1979) Meth. Enzymol. 68:109-51;the diethylphosphoramidite method of Beaucage, et al., (1981) Tetra.Letts. 22(20):1859-62; the solid phase phosphoramidite triester methoddescribed by Beaucage, et al., supra, e.g., using an automatedsynthesizer, e.g., as described in Needham-VanDevanter, et al., (1984)Nucleic Acids Res. 12:6159-68 and the solid support method of U.S. Pat.No. 4,458,066. Chemical synthesis generally produces a single strandedoligonucleotide. This may be converted into double stranded DNA byhybridization with a complementary sequence or by polymerization with aDNA polymerase using the single strand as a template. One of skill willrecognize that while chemical synthesis of DNA is limited to sequencesof about 100 bases, longer sequences may be obtained by the ligation ofshorter sequences.

UTRs and Codon Preference

In general, translational efficiency has been found to be regulated byspecific sequence elements in the 5′ non-coding or untranslated region(5′ UTR) of the RNA. Positive sequence motifs include translationalinitiation consensus sequences (Kozak, (1987) Nucleic Acids Res.15:8125) and the 5<G> 7 methyl GpppG RNA cap structure (Drummond, etal., (1985) Nucleic Acids Res. 13:7375). Negative elements includestable intramolecular 5′ UTR stem-loop structures (Muesing, et al.,(1987) Cell 48:691) and AUG sequences or short open reading framespreceded by an appropriate AUG in the 5′ UTR (Kozak, supra, Rao, et al.,(1988) Mol. and Cell. Biol. 8:284). Accordingly, the present inventionprovides 5′ and/or 3′ UTR regions for modulation of translation ofheterologous coding sequences.

Further, the polypeptide-encoding segments of the polynucleotides of thepresent invention can be modified to alter codon usage. Altered codonusage can be employed to alter translational efficiency and/or tooptimize the coding sequence for expression in a desired host or tooptimize the codon usage in a heterologous sequence for expression inmaize. Codon usage in the coding regions of the polynucleotides of thepresent invention can be analyzed statistically using commerciallyavailable software packages such as “Codon Preference” available fromthe University of Wisconsin Genetics Computer Group. See, Devereaux, etal., (1984) Nucleic Acids Res. 12:387-395) or MacVector 4.1 (EastmanKodak Co., New Haven, Conn.). Thus, the present invention provides acodon usage frequency characteristic of the coding region of at leastone of the polynucleotides of the present invention. The number ofpolynucleotides (3 nucleotides per amino acid) that can be used todetermine a codon usage frequency can be any integer from 3 to thenumber of polynucleotides of the present invention as provided herein.Optionally, the polynucleotides will be full-length sequences. Anexemplary number of sequences for statistical analysis can be at least1, 5, 10, 20, 50 or 100.

Sequence Shuffling

The present invention provides methods for sequence shuffling usingpolynucleotides of the present invention, and compositions resultingtherefrom. Sequence shuffling is described in PCT Publication Number96/19256. See also, Zhang, et al., (1997) Proc. Natl. Acad. Sci. USA94:4504-9 and Zhao, et al., (1998) Nature Biotech 16:258-61. Generally,sequence shuffling provides a means for generating libraries ofpolynucleotides having a desired characteristic, which can be selectedor screened for. Libraries of recombinant polynucleotides are generatedfrom a population of related sequence polynucleotides, which comprisesequence regions, which have substantial sequence identity and can behomologously recombined in vitro or in vivo. The population ofsequence-recombined polynucleotides comprises a subpopulation ofpolynucleotides which possess desired or advantageous characteristicsand which can be selected by a suitable selection or screening method.The characteristics can be any property or attribute capable of beingselected for or detected in a screening system, and may includeproperties of: an encoded protein, a transcriptional element, a sequencecontrolling transcription, RNA processing, RNA stability, chromatinconformation, translation or other expression property of a gene ortransgene, a replicative element, a protein-binding element or the like,such as any feature which confers a selectable or detectable property.In some embodiments, the selected characteristic will be an alteredK_(m) and/or K_(cat) over the wild-type protein as provided herein. Inother embodiments, a protein or polynucleotide generated from sequenceshuffling will have a ligand binding affinity greater than thenon-shuffled wild-type polynucleotide. In yet other embodiments, aprotein or polynucleotide generated from sequence shuffling will have analtered pH optimum as compared to the non-shuffled wild-typepolynucleotide. The increase in such properties can be at least 110%,120%, 130%, 140% or greater than 150% of the wild-type value.

Recombinant Expression Cassettes

The present invention further provides recombinant expression cassettescomprising a nucleic acid of the present invention. A nucleic acidsequence coding for the desired polynucleotide of the present invention,for example a cDNA or a genomic sequence encoding a polypeptide longenough to code for an active protein of the present invention, can beused to construct a recombinant expression cassette which can beintroduced into the desired host cell. A recombinant expression cassettewill typically comprise a polynucleotide of the present inventionoperably linked to transcriptional initiation regulatory sequences whichwill direct the transcription of the polynucleotide in the intended hostcell, such as tissues of a transformed plant.

For example, plant expression vectors may include (1) a cloned plantgene under the transcriptional control of 5′ and 3′ regulatory sequencesand (2) a dominant selectable marker. Such plant expression vectors mayalso contain, if desired, a promoter regulatory region (e.g., oneconferring inducible or constitutive, environmentally- ordevelopmentally-regulated, or cell- or tissue-specific/selectiveexpression), a transcription initiation start site, a ribosome bindingsite, an RNA processing signal, a transcription termination site and/ora polyadenylation signal.

A plant promoter fragment can be employed which will direct expressionof a polynucleotide of the present invention in all tissues of aregenerated plant. Such promoters are referred to herein as“constitutive” promoters and are active under most environmentalconditions and states of development or cell differentiation. Examplesof constitutive promoters include the 1′- or 2′-promoter derived fromT-DNA of Agrobacterium tumefaciens, the Smas promoter, the cinnamylalcohol dehydrogenase promoter (U.S. Pat. No. 5,683,439), the Nospromoter, the rubisco promoter, the GRP1-8 promoter, the 35S promoterfrom cauliflower mosaic virus (CaMV), as described in Odell, et al.,(1985) Nature 313:810-2; rice actin (McElroy, et al., (1990) Plant Cell163-171); ubiquitin (Christensen, et al., (1992) Plant Mol. Biol.12:619-632 and Christensen, et al., (1992) Plant Mol. Biol. 18:675-89);pEMU (Last, et al., (1991) Theor. Appl. Genet. 81:581-8); MAS (Velten,et al., (1984) EMBO J. 3:2723-30) and maize H3 histone (Lepetit, et al.,(1992) Mol. Gen. Genet. 231:276-85 and Atanassvoa, et al., (1992) PlantJournal 2(3):291-300); ALS promoter, as described in PCT ApplicationNumber WO 1996/30530 and other transcription initiation regions fromvarious plant genes known to those of skill. For the present inventionubiquitin is the preferred promoter for expression in monocot plants.

Alternatively, the plant promoter can direct expression of apolynucleotide of the present invention in a specific tissue or may beotherwise under more precise environmental or developmental control.Such promoters are referred to here as “inducible” promoters.Environmental conditions that may effect transcription by induciblepromoters include pathogen attack, anaerobic conditions or the presenceof light. Examples of inducible promoters are the Adh1 promoter, whichis inducible by hypoxia or cold stress, the Hsp70 promoter, which isinducible by heat stress and the PPDK promoter, which is inducible bylight.

Examples of promoters under developmental control include promoters thatinitiate transcription only, or preferentially, in certain tissues, suchas leaves, roots, fruit, seeds or flowers. The operation of a promotermay also vary depending on its location in the genome. Thus, aninducible promoter may become fully or partially constitutive in certainlocations.

If polypeptide expression is desired, it is generally desirable toinclude a polyadenylation region at the 3′-end of a polynucleotidecoding region. The polyadenylation region can be derived from a varietyof plant genes, or from T-DNA. The 3′ end sequence to be added can bederived from, for example, the nopaline synthase or octopine synthasegenes or alternatively from another plant gene or less preferably fromany other eukaryotic gene. Examples of such regulatory elements include,but are not limited to, 3′ termination and/or polyadenylation regionssuch as those of the Agrobacterium tumefaciens nopaline synthase (nos)gene (Bevan, et al., (1983) Nucleic Acids Res. 12:369-85); the potatoproteinase inhibitor II (PINII) gene (Keil, et al., (1986) Nucleic AcidsRes. 14:5641-50 and An, et al., (1989) Plant Cell 1:115-22) and the CaMV19S gene (Mogen, et al., (1990) Plant Cell 2:1261-72).

An intron sequence can be added to the 5′ untranslated region or thecoding sequence of the partial coding sequence to increase the amount ofthe mature message that accumulates in the cytosol. Inclusion of aspliceable intron in the transcription unit in both plant and animalexpression constructs has been shown to increase gene expression at boththe mRNA and protein levels up to 1000-fold (Buchman and Berg, (1988)Mol. Cell. Biol. 8:4395-4405; Callis, et al., (1987) Genes Dev.1:1183-200). Such intron enhancement of gene expression is typicallygreatest when placed near the 5′ end of the transcription unit. Use ofmaize introns Adh1-S intron 1, 2 and 6, the Bronze-1 intron are known inthe art. See generally, The Maize Handbook, Chapter 116, Freeling andWalbot, eds., Springer, New York (1994).

Plant signal sequences, including, but not limited to, signal-peptideencoding DNA/RNA sequences which target proteins to the extracellularmatrix of the plant cell (Dratewka-Kos, et al., (1989) J. Biol. Chem.264:4896-900), such as the Nicotiana plumbaginifolia extension gene(DeLoose, et al., (1991) Gene 99:95-100); signal peptides which targetproteins to the vacuole, such as the sweet potato sporamin gene(Matsuka, et al., (1991) Proc. Natl. Acad. Sci. USA 88:834) and thebarley lectin gene (Wilkins, et al., (1990) Plant Cell, 2:301-13);signal peptides which cause proteins to be secreted, such as that ofPRIb (Lind, et al., (1992) Plant Mol. Biol. 18:47-53) or the barleyalpha amylase (BAA) (Rahmatullah, et al., (1989) Plant Mol. Biol. 12:119and hereby incorporated by reference) or signal peptides which targetproteins to the plastids such as that of rapeseed enoyl-Acp reductase(Verwaert, et al., (1994) Plant Mol. Biol. 26:189-202) are useful in theinvention.

The vector comprising the sequences from a polynucleotide of the presentinvention will typically comprise a marker gene, which confers aselectable phenotype on plant cells. Usually, the selectable marker genewill encode antibiotic resistance, with suitable genes including genescoding for resistance to the antibiotic spectinomycin (e.g., the aadagene), the streptomycin phosphotransferase (SPT) gene coding forstreptomycin resistance, the neomycin phosphotransferase (NPTII) geneencoding kanamycin or geneticin resistance, the hygromycinphosphotransferase (HPT) gene coding for hygromycin resistance, genescoding for resistance to herbicides which act to inhibit the action ofacetolactate synthase (ALS), in particular the sulfonylurea-typeherbicides (e.g., the acetolactate synthase (ALS) gene containingmutations leading to such resistance in particular the S4 and/or Hramutations), genes coding for resistance to herbicides which act toinhibit action of glutamine synthase, such as phosphinothricin or basta(e.g., the bar gene), or other such genes known in the art. The bar geneencodes resistance to the herbicide basta and the ALS gene encodesresistance to the herbicide chlorsulfuron.

Typical vectors useful for expression of genes in higher plants are wellknown in the art and include vectors derived from the tumor-inducing(Ti) plasmid of Agrobacterium tumefaciens described by Rogers, et al.,(1987) Meth. Enzymol. 153:253-77. These vectors are plant integratingvectors in that on transformation, the vectors integrate a portion ofvector DNA into the genome of the host plant. Exemplary A. tumefaciensvectors useful herein are plasmids pKYLX6 and pKYLX7 of Schardl, et al.,(1987) Gene 61:1-11 and Berger, et al., (1989) Proc. Natl. Acad. Sci.USA, 86:8402-6. Another useful vector herein is plasmid pBI101.2 that isavailable from CLONTECH Laboratories, Inc. (Palo Alto, Calif.).

Expression of Proteins in Host Cells

Using the nucleic acids of the present invention, one may express aprotein of the present invention in a recombinantly engineered cell suchas bacteria, yeast, insect, mammalian or preferably plant cells. Thecells produce the protein in a non-natural condition (e.g., in quantity,composition, location and/or time), because they have been geneticallyaltered through human intervention to do so.

It is expected that those of skill in the art are knowledgeable in thenumerous expression systems available for expression of a nucleic acidencoding a protein of the present invention. No attempt to describe indetail the various methods known for the expression of proteins inprokaryotes or eukaryotes will be made.

In brief summary, the expression of isolated nucleic acids encoding aprotein of the present invention will typically be achieved by operablylinking, for example, the DNA or cDNA to a promoter (which is eitherconstitutive or inducible), followed by incorporation into an expressionvector. The vectors can be suitable for replication and integration ineither prokaryotes or eukaryotes. Typical expression vectors containtranscription and translation terminators, initiation sequences andpromoters useful for regulation of the expression of the DNA encoding aprotein of the present invention. To obtain high level expression of acloned gene, it is desirable to construct expression vectors whichcontain, at the minimum, a strong promoter, such as ubiquitin, to directtranscription, a ribosome binding site for translational initiation anda transcription/translation terminator. Constitutive promoters areclassified as providing for a range of constitutive expression. Thus,some are weak constitutive promoters and others are strong constitutivepromoters. Generally, by “weak promoter” is intended a promoter thatdrives expression of a coding sequence at a low level. By “low level” isintended at levels of about 1/10,000 transcripts to about 1/100,000transcripts to about 1/500,000 transcripts. Conversely, a “strongpromoter” drives expression of a coding sequence at a “high level,” orabout 1/10 transcripts to about 1/100 transcripts to about 1/1,000transcripts.

One of skill would recognize that modifications could be made to aprotein of the present invention without diminishing its biologicalactivity. Some modifications may be made to facilitate the cloning,expression or incorporation of the targeting molecule into a fusionprotein. Such modifications are well known to those of skill in the artand include, for example, a methionine added at the amino terminus toprovide an initiation site or additional amino acids (e.g., poly His)placed on either terminus to create conveniently located restrictionsites or termination codons or purification sequences.

Expression in Prokaryotes

Prokaryotic cells may be used as hosts for expression. Prokaryotes mostfrequently are represented by various strains of E. coli; however, othermicrobial strains may also be used. Commonly used prokaryotic controlsequences which are defined herein to include promoters fortranscription initiation, optionally with an operator, along withribosome binding site sequences, include such commonly used promoters asthe beta lactamase (penicillinase) and lactose (lac) promoter systems(Chang, et al., (1977) Nature 198:1056), the tryptophan (trp) promotersystem (Goeddel, et al., (1980) Nucleic Acids Res. 8:4057) and thelambda derived P L promoter and N-gene ribosome binding site (Shimatake,et al., (1981) Nature 292:128). The inclusion of selection markers inDNA vectors transfected in E. coli is also useful. Examples of suchmarkers include genes specifying resistance to ampicillin, tetracyclineor chloramphenicol.

The vector is selected to allow introduction of the gene of interestinto the appropriate host cell. Bacterial vectors are typically ofplasmid or phage origin. Appropriate bacterial cells are infected withphage vector particles or transfected with naked phage vector DNA. If aplasmid vector is used, the bacterial cells are transfected with theplasmid vector DNA. Expression systems for expressing a protein of thepresent invention are available using Bacillus sp. and Salmonella(Palva, et al., (1983) Gene 22:229-35; Mosbach, et al., (1983) Nature302:543-5). The pGEX-4T-1 plasmid vector from Pharmacia is the preferredE. coli expression vector for the present invention.

Expression in Eukaryotes

A variety of eukaryotic expression systems such as yeast, insect celllines, plant and mammalian cells, are known to those of skill in theart. As explained briefly below, the present invention can be expressedin these eukaryotic systems. In some embodiments,transformed/transfected plant cells, as discussed infra, are employed asexpression systems for production of the proteins of the instantinvention.

Synthesis of heterologous proteins in yeast is well known. Sherman, etal., (1982) Methods in Yeast Genetics, Cold Spring Harbor Laboratory isa well recognized work describing the various methods available toproduce the protein in yeast. Two widely utilized yeasts for productionof eukaryotic proteins are Saccharomyces cerevisiae and Pichia pastoris.Vectors, strains and protocols for expression in Saccharomyces andPichia are known in the art and available from commercial suppliers(e.g., Invitrogen). Suitable vectors usually have expression controlsequences, such as promoters, including 3-phosphoglycerate kinase oralcohol oxidase and an origin of replication, termination sequences andthe like as desired.

A protein of the present invention, once expressed, can be isolated fromyeast by lysing the cells and applying standard protein isolationtechniques to the lysates or the pellets. The monitoring of thepurification process can be accomplished by using Western blottechniques or radioimmunoassay of other standard immunoassay techniques.

The sequences encoding proteins of the present invention can also beligated to various expression vectors for use in transfecting cellcultures of, for instance, mammalian, insect or plant origin. Mammaliancell systems often will be in the form of monolayers of cells althoughmammalian cell suspensions may also be used. A number of suitable hostcell lines capable of expressing intact proteins have been developed inthe art, and include the HEK293, BHK21 and CHO cell lines. Expressionvectors for these cells can include expression control sequences, suchas an origin of replication, a promoter (e.g., the CMV promoter, a HSVtk promoter or pgk (phosphoglycerate kinase) promoter), an enhancer(Queen, et al., (1986) Immunol. Rev. 89:49) and necessary processinginformation sites, such as ribosome binding sites, RNA splice sites,polyadenylation sites (e.g., an SV40 large T Ag poly A addition site)and transcriptional terminator sequences. Other animal cells useful forproduction of proteins of the present invention are available, forinstance, from the American Type Culture Collection Catalogue of CellLines and Hybridomas (7^(th) ed., 1992). Appropriate vectors forexpressing proteins of the present invention in insect cells are usuallyderived from the SF9 baculovirus. Suitable insect cell lines includemosquito larvae, silkworm, armyworm, moth and Drosophila cell lines suchas a Schneider cell line (see, e.g., Schneider, (1987) J. Embryol. Exp.Morphol. 27:353-65).

As with yeast, when higher animal or plant host cells are employed,polyadenlyation or transcription terminator sequences are typicallyincorporated into the vector. An example of a terminator sequence is thepolyadenlyation sequence from the bovine growth hormone gene. Sequencesfor accurate splicing of the transcript may also be included. An exampleof a splicing sequence is the VP1 intron from SV40 (Sprague, et al.,(1983) J. Virol. 45:773-81). Additionally, gene sequences to controlreplication in the host cell may be incorporated into the vector such asthose found in bovine papilloma virus type-vectors (Saveria-Campo,“Bovine Papilloma Virus DNA a Eukaryotic Cloning Vector,” in DNACloning: A Practical Approach, vol. II, Glover, ed., IRL Press,Arlington, Va., pp. 213-38 (1985)).

In addition, the NUE gene placed in the appropriate plant expressionvector can be used to transform plant cells. The polypeptide can then beisolated from plant callus or the transformed cells can be used toregenerate transgenic plants. Such transgenic plants can be harvested,and the appropriate tissues (seed or leaves, for example) can besubjected to large scale protein extraction and purification techniques.

Plant Transformation Methods

Numerous methods for introducing foreign genes into plants are known andcan be used to insert an NUE polynucleotide into a plant host, includingbiological and physical plant transformation protocols. See, e.g., Mikiet al., “Procedure for Introducing Foreign DNA into Plants,” in Methodsin Plant Molecular Biology and Biotechnology, Glick and Thompson, eds.,CRC Press, Inc., Boca Raton, pp. 67-88 (1993). The methods chosen varywith the host plant, and include chemical transfection methods such ascalcium phosphate, microorganism-mediated gene transfer such asAgrobacterium (Horsch, et al., (1985) Science 227:1229-31),electroporation, micro-injection and biolistic bombardment.

Expression cassettes and vectors and in vitro culture methods for plantcell or tissue transformation and regeneration of plants are known andavailable. See, e.g., Gruber, et al., “Vectors for PlantTransformation,” in Methods in Plant Molecular Biology andBiotechnology, supra, pp. 89-119.

The isolated polynucleotides or polypeptides may be introduced into theplant by one or more techniques typically used for direct delivery intocells. Such protocols may vary depending on the type of organism, cell,plant or plant cell, i.e., monocot or dicot, targeted for genemodification. Suitable methods of transforming plant cells includemicroinjection (Crossway, et al., (1986) Biotechniques 4:320-334 andU.S. Pat. No. 6,300,543), electroporation (Riggs, et al., (1986) Proc.Natl. Acad. Sci. USA 83:5602-5606, direct gene transfer (Paszkowski etal., (1984) EMBO J. 3:2717-2722) and ballistic particle acceleration(see, for example, Sanford, et al., U.S. Pat. No. 4,945,050; WO1991/10725 and McCabe, et al., (1988) Biotechnology 6:923-926). Alsosee, Tomes, et al., “Direct DNA Transfer into Intact Plant Cells ViaMicroprojectile Bombardment”. pp. 197-213 in Plant Cell, Tissue andOrgan Culture, Fundamental Methods. eds. Gamborg and Phillips.Springer-Verlag Berlin Heidelberg New York, 1995; U.S. Pat. No.5,736,369 (meristem); Weissinger, et al., (1988) Ann. Rev. Genet.22:421-477; Sanford, et al., (1987) Particulate Science and Technology5:27-37 (onion); Christou, et al., (1988) Plant Physiol. 87:671-674(soybean); Datta, et al., (1990) Biotechnology 8:736-740 (rice); Klein,et al., (1988) Proc. Natl. Acad. Sci. USA 85:4305-4309 (maize); Klein,et al., (1988) Biotechnology 6:559-563 (maize); WO 1991/10725 (maize);Klein, et al., (1988) Plant Physiol. 91:440-444 (maize); Fromm, et al.,(1990) Biotechnology 8:833-839 and Gordon-Kamm, et al., (1990) PlantCell 2:603-618 (maize); Hooydaas-Van Slogteren and Hooykaas, (1984)Nature (London) 311:763-764; Bytebierm, et al., (1987) Proc. Natl. Acad.Sci. USA 84:5345-5349 (Liliaceae); De Wet, et al., (1985) In TheExperimental Manipulation of Ovule Tissues, ed. G. P. Chapman, et al.,pp. 197-209. Longman, N Y (pollen); Kaeppler, et al., (1990) Plant CellReports 9:415-418 and Kaeppler, et al., (1992) Theor. Appl. Genet.84:560-566 (whisker-mediated transformation); U.S. Pat. No. 5,693,512(sonication); D'Halluin, et al., (1992) Plant Cell 4:1495-1505(electroporation); Li, et al., (1993) Plant Cell Reports 12:250-255 andChristou and Ford, (1995) Annals of Botany 75:407-413 (rice); Osjoda, etal., (1996) Nature Biotech. 14:745-750; Agrobacterium mediated maizetransformation (U.S. Pat. No. 5,981,840); silicon carbide whiskermethods (Frame, et al., (1994) Plant J. 6:941-948); laser methods (Guo,et al., (1995) Physiologia Plantarum 93:19-24); sonication methods (Bao,et al., (1997) Ultrasound in Medicine & Biology 23:953-959; Finer andFiner, (2000) Lett Appl Microbiol. 30:406-10; Amoah, et al., (2001) JExp Bot 52:1135-42); polyethylene glycol methods (Krens, et al., (1982)Nature 296:72-77); protoplasts of monocot and dicot cells can betransformed using electroporation (Fromm, et al., (1985) Proc. Natl.Acad. Sci. USA 82:5824-5828) and microinjection (Crossway, et al.,(1986) Mol. Gen. Genet. 202:179-185), all of which are hereinincorporated by reference.

Agrobacterium-Mediated Transformation

The most widely utilized method for introducing an expression vectorinto plants is based on the natural transformation system ofAgrobacterium. A. tumefaciens and A. rhizogenes are plant pathogenicsoil bacteria, which genetically transform plant cells. The Ti and Riplasmids of A. tumefaciens and A. rhizogenes, respectively, carry genesresponsible for genetic transformation of plants. See, e.g., Kado,(1991) Crit. Rev. Plant Sci. 10:1. Descriptions of the Agrobacteriumvector systems and methods for Agrobacterium-mediated gene transfer areprovided in Gruber, et al., supra; Miki, et al., supra and Moloney, etal., (1989) Plant Cell Reports 8:238.

Similarly, the gene can be inserted into the T-DNA region of a Ti or Riplasmid derived from A. tumefaciens or A. rhizogenes, respectively.Thus, expression cassettes can be constructed as above, using theseplasmids. Many control sequences are known which when coupled to aheterologous coding sequence and transformed into a host organism showfidelity in gene expression with respect to tissue/organ specificity ofthe original coding sequence. See, e.g., Benfey and Chua, (1989) Science244:174-81. Particularly suitable control sequences for use in theseplasmids are promoters for constitutive leaf-specific expression of thegene in the various target plants. Other useful control sequencesinclude a promoter and terminator from the nopaline synthase gene (NOS).The NOS promoter and terminator are present in the plasmid pARC2,available from the American Type Culture Collection and designated ATCC67238. If such a system is used, the virulence (vir) gene from eitherthe Ti or Ri plasmid must also be present, either along with the T-DNAportion, or via a binary system where the vir gene is present on aseparate vector. Such systems, vectors for use therein, and methods oftransforming plant cells are described in U.S. Pat. No. 4,658,082; U.S.patent application Ser. No. 913,914, filed Oct. 1, 1986, as referencedin U.S. Pat. No. 5,262,306, issued Nov. 16, 1993 and Simpson, et al.,(1986) Plant Mol. Biol. 6:403-15 (also referenced in the '306 patent),all incorporated by reference in their entirety.

Once constructed, these plasmids can be placed into A. rhizogenes or A.tumefaciens and these vectors used to transform cells of plant species,which are ordinarily susceptible to Fusarium or Alternaria infection.Several other transgenic plants are also contemplated by the presentinvention including but not limited to soybean, corn, sorghum, alfalfa,rice, clover, cabbage, banana, coffee, celery, tobacco, cowpea, cotton,melon and pepper. The selection of either A. tumefaciens or A.rhizogenes will depend on the plant being transformed thereby. Ingeneral A. tumefaciens is the preferred organism for transformation.Most dicotyledonous plants, some gymnosperms and a few monocotyledonousplants (e.g., certain members of the Liliales and Arales) aresusceptible to infection with A. tumefaciens. A. rhizogenes also has awide host range, embracing most dicots and some gymnosperms, whichincludes members of the Leguminosae, Compositae, and Chenopodiaceae.Monocot plants can now be transformed with some success. EP PatentApplication Number 604 662 A1 discloses a method for transformingmonocots using Agrobacterium. EP Patent Application Number 672 752 A1discloses a method for transforming monocots with Agrobacterium usingthe scutellum of immature embryos. Ishida, et al., discuss a method fortransforming maize by exposing immature embryos to A. tumefaciens(Nature Biotechnology 14:745-50 (1996)).

Once transformed, these cells can be used to regenerate transgenicplants. For example, whole plants can be infected with these vectors bywounding the plant and then introducing the vector into the wound site.Any part of the plant can be wounded, including leaves, stems and roots.Alternatively, plant tissue, in the form of an explant, such ascotyledonary tissue or leaf disks, can be inoculated with these vectors,and cultured under conditions, which promote plant regeneration. Rootsor shoots transformed by inoculation of plant tissue with A. rhizogenesor A. tumefaciens, containing the gene coding for the fumonisindegradation enzyme, can be used as a source of plant tissue toregenerate fumonisin-resistant transgenic plants, either via somaticembryogenesis or organogenesis. Examples of such methods forregenerating plant tissue are disclosed in Shahin, (1985) Theor. Appl.Genet. 69:235-40; U.S. Pat. No. 4,658,082; Simpson, et al., supra andU.S. patent application Ser. Nos. 913,913 and 913,914, both filed Oct.1, 1986, as referenced in U.S. Pat. No. 5,262,306, issued Nov. 16, 1993,the entire disclosures therein incorporated herein by reference.

Direct Gene Transfer

Despite the fact that the host range for Agrobacterium-mediatedtransformation is broad, some major cereal crop species and gymnospermshave generally been recalcitrant to this mode of gene transfer, eventhough some success has recently been achieved in rice (Hiei, et al.,(1994) The Plant Journal 6:271-82). Several methods of planttransformation, collectively referred to as direct gene transfer, havebeen developed as an alternative to Agrobacterium-mediatedtransformation.

A generally applicable method of plant transformation ismicroprojectile-mediated transformation, where DNA is carried on thesurface of microprojectiles measuring about 1 to 4 μm. The expressionvector is introduced into plant tissues with a biolistic device thataccelerates the microprojectiles to speeds of 300 to 600 m/s which issufficient to penetrate the plant cell walls and membranes (Sanford, etal., (1987) Part. Sci. Technol. 5:27; Sanford, (1988) Trends Biotech6:299; Sanford, (1990) Physiol. Plant 79:206 and Klein, et al., (1992)Biotechnology 10:268).

Another method for physical delivery of DNA to plants is sonication oftarget cells as described in Zang, et al., (1991) BioTechnology 9:996.Alternatively, liposome or spheroplast fusions have been used tointroduce expression vectors into plants. See, e.g., Deshayes, et al.,(1985) EMBO J. 4:2731 and Christou, et al., (1987) Proc. Natl. Acad.Sci. USA 84:3962. Direct uptake of DNA into protoplasts using CaCl₂precipitation, polyvinyl alcohol, or poly-L-ornithine has also beenreported. See, e.g., Hain, et al., (1985) Mol. Gen. Genet. 199:161 andDraper, et al., (1982) Plant Cell Physiol. 23:451. Electroporation ofprotoplasts and whole cells and tissues has also been described.

See, e.g., Donn, et al., (1990) Abstracts of the VIIth Int'l. Congresson Plant Cell and Tissue Culture IAPTC, A2-38, p. 53; D'Halluin, et al.,(1992) Plant Cell 4:1495-505 and Spencer, et al., (1994) Plant Mol.Biol. 24:51-61.

Increasing the Activity and/or Level of a NUE Polypeptide

Methods are provided to increase the activity and/or level of the NUEpolypeptide of the invention. An increase in the level and/or activityof the NUE polypeptide of the invention can be achieved by providing tothe plant a NUE polypeptide. The NUE polypeptide can be provided byintroducing the amino acid sequence encoding the NUE polypeptide intothe plant, introducing into the plant a nucleotide sequence encoding aNUE polypeptide or alternatively by modifying a genomic locus encodingthe NUE polypeptide of the invention.

As discussed elsewhere herein, many methods are known the art forproviding a polypeptide to a plant including, but not limited to, directintroduction of the polypeptide into the plant, introducing into theplant (transiently or stably) a polynucleotide construct encoding apolypeptide having enhanced nitrogen utilization activity. It is alsorecognized that the methods of the invention may employ a polynucleotidethat is not capable of directing, in the transformed plant, theexpression of a protein or an RNA. Thus, the level and/or activity of aNUE polypeptide may be increased by altering the gene encoding the NUEpolypeptide or its promoter. See, e.g., Kmiec, U.S. Pat. No. 5,565,350;Zarling, et al., PCT/US93/03868. Therefore mutagenized plants that carrymutations in NUE genes, where the mutations increase expression of theNUE gene or increase the NUE activity of the encoded NUE polypeptide areprovided.

Reducing the Activity and/or Level of a NUE Polypeptide

Methods are provided to reduce or eliminate the activity of a NUEpolypeptide of the invention by transforming a plant cell with anexpression cassette that expresses a polynucleotide that inhibits theexpression of the NUE polypeptide. The polynucleotide may inhibit theexpression of the NUE polypeptide directly, by preventing transcriptionor translation of the NUE messenger RNA, or indirectly, by encoding apolypeptide that inhibits the transcription or translation of an NUEgene encoding NUE polypeptide. Methods for inhibiting or eliminating theexpression of a gene in a plant are well known in the art and any suchmethod may be used in the present invention to inhibit the expression ofNUE polypeptide.

In accordance with the present invention, the expression of NUEpolypeptide is inhibited if the protein level of the NUE polypeptide isless than 70% of the protein level of the same NUE polypeptide in aplant that has not been genetically modified or mutagenized to inhibitthe expression of that NUE polypeptide. In particular embodiments of theinvention, the protein level of the NUE polypeptide in a modified plantaccording to the invention is less than 60%, less than 50%, less than40%, less than 30%, less than 20%, less than 10%, less than 5% or lessthan 2% of the protein level of the same NUE polypeptide in a plant thatis not a mutant or that has not been genetically modified to inhibit theexpression of that NUE polypeptide. The expression level of the NUEpolypeptide may be measured directly, for example, by assaying for thelevel of NUE polypeptide expressed in the plant cell or plant, orindirectly, for example, by measuring the nitrogen uptake activity ofthe NUE polypeptide in the plant cell or plant or by measuring thephenotypic changes in the plant. Methods for performing such assays aredescribed elsewhere herein.

In other embodiments of the invention, the activity of the NUEpolypeptides is reduced or eliminated by transforming a plant cell withan expression cassette comprising a polynucleotide encoding apolypeptide that inhibits the activity of a NUE polypeptide. Theenhanced nitrogen utilization activity of a NUE polypeptide is inhibitedaccording to the present invention if the NUE activity of the NUEpolypeptide is less than 70% of the NUE activity of the same NUEpolypeptide in a plant that has not been modified to inhibit the NUEactivity of that NUE polypeptide. In particular embodiments of theinvention, the NUE activity of the NUE polypeptide in a modified plantaccording to the invention is less than 60%, less than 50%, less than40%, less than 30%, less than 20%, less than 10% or less than 5% of theNUE activity of the same NUE polypeptide in a plant that that has notbeen modified to inhibit the expression of that NUE polypeptide. The NUEactivity of a NUE polypeptide is “eliminated” according to the inventionwhen it is not detectable by the assay methods described elsewhereherein. Methods of determining the alteration of nitrogen utilizationactivity of a NUE polypeptide are described elsewhere herein.

In other embodiments, the activity of a NUE polypeptide may be reducedor eliminated by disrupting the gene encoding the NUE polypeptide. Theinvention encompasses mutagenized plants that carry mutations in NUEgenes, where the mutations reduce expression of the NUE gene or inhibitthe nitrogen utilization activity of the encoded NUE polypeptide.

Thus, many methods may be used to reduce or eliminate the activity of aNUE polypeptide. In addition, more than one method may be used to reducethe activity of a single NUE polypeptide.

1. Polynucleotide-Based Methods:

In some embodiments of the present invention, a plant is transformedwith an expression cassette that is capable of expressing apolynucleotide that inhibits the expression of an NUE polypeptide of theinvention. The term “expression” as used herein refers to thebiosynthesis of a gene product, including the transcription and/ortranslation of said gene product. For example, for the purposes of thepresent invention, an expression cassette capable of expressing apolynucleotide that inhibits the expression of at least one NUEpolypeptide is an expression cassette capable of producing an RNAmolecule that inhibits the transcription and/or translation of at leastone NUE polypeptide of the invention. The “expression” or “production”of a protein or polypeptide from a DNA molecule refers to thetranscription and translation of the coding sequence to produce theprotein or polypeptide, while the “expression” or “production” of aprotein or polypeptide from an RNA molecule refers to the translation ofthe RNA coding sequence to produce the protein or polypeptide.

Examples of polynucleotides that inhibit the expression of a NUEpolypeptide are given below.

i. Sense Suppression/Cosuppression

In some embodiments of the invention, inhibition of the expression of aNUE polypeptide may be obtained by sense suppression or cosuppression.For cosuppression, an expression cassette is designed to express an RNAmolecule corresponding to all or part of a messenger RNA encoding a NUEpolypeptide in the “sense” orientation. Over expression of the RNAmolecule can result in reduced expression of the native gene.Accordingly, multiple plant lines transformed with the cosuppressionexpression cassette are screened to identify those that show thegreatest inhibition of NUE polypeptide expression.

The polynucleotide used for cosuppression may correspond to all or partof the sequence encoding the NUE polypeptide, all or part of the 5′and/or 3′ untranslated region of a NUE polypeptide transcript or all orpart of both the coding sequence and the untranslated regions of atranscript encoding a NUE polypeptide. In some embodiments where thepolynucleotide comprises all or part of the coding region for the NUEpolypeptide, the expression cassette is designed to eliminate the startcodon of the polynucleotide so that no protein product will betranslated.

Cosuppression may be used to inhibit the expression of plant genes toproduce plants having undetectable protein levels for the proteinsencoded by these genes. See, for example, Broin, et al., (2002) PlantCell 14:1417-1432. Cosuppression may also be used to inhibit theexpression of multiple proteins in the same plant. See, for example,U.S. Pat. No. 5,942,657. Methods for using cosuppression to inhibit theexpression of endogenous genes in plants are described in Flavell, etal., (1994) Proc. Natl. Acad. Sci. USA 91:3490-3496; Jorgensen, et al.,(1996) Plant Mol. Biol. 31:957-973; Johansen and Carrington, (2001)Plant Physiol. 126:930-938; Broin, et al., (2002) Plant Cell14:1417-1432; Stoutjesdijk, et al., (2002) Plant Physiol. 129:1723-1731;Yu, et al., (2003) Phytochemistry 63:753-763 and U.S. Pat. Nos.5,034,323, 5,283,184 and 5,942,657, each of which is herein incorporatedby reference. The efficiency of cosuppression may be increased byincluding a poly-dT region in the expression cassette at a position 3′to the sense sequence and 5′ of the polyadenylation signal. See, USPatent Application Publication Number 2002/0048814, herein incorporatedby reference. Typically, such a nucleotide sequence has substantialsequence identity to the sequence of the transcript of the endogenousgene, optimally greater than about 65% sequence identity, more optimallygreater than about 85% sequence identity, most optimally greater thanabout 95% sequence identity. See U.S. Pat. Nos. 5,283,184 and 5,034,323,herein incorporated by reference.

ii. Antisense Suppression

In some embodiments of the invention, inhibition of the expression ofthe NUE polypeptide may be obtained by antisense suppression. Forantisense suppression, the expression cassette is designed to express anRNA molecule complementary to all or part of a messenger RNA encodingthe NUE polypeptide. Over expression of the antisense RNA molecule canresult in reduced expression of the native gene. Accordingly, multipleplant lines transformed with the antisense suppression expressioncassette are screened to identify those that show the greatestinhibition of NUE polypeptide expression.

The polynucleotide for use in antisense suppression may correspond toall or part of the complement of the sequence encoding the NUEpolypeptide, all or part of the complement of the 5′ and/or 3′untranslated region of the NUE transcript or all or part of thecomplement of both the coding sequence and the untranslated regions of atranscript encoding the NUE polypeptide. In addition, the antisensepolynucleotide may be fully complementary (i.e., 100% identical to thecomplement of the target sequence) or partially complementary (i.e.,less than 100% identical to the complement of the target sequence) tothe target sequence. Antisense suppression may be used to inhibit theexpression of multiple proteins in the same plant. See, for example,U.S. Pat. No. 5,942,657. Furthermore, portions of the antisensenucleotides may be used to disrupt the expression of the target gene.Generally, sequences of at least 50 nucleotides, 100 nucleotides, 200nucleotides, 300, 400, 450, 500, 550 or greater may be used. Methods forusing antisense suppression to inhibit the expression of endogenousgenes in plants are described, for example, in Liu, et al., (2002) PlantPhysiol. 129:1732-1743 and U.S. Pat. Nos. 5,759,829 and 5,942,657, eachof which is herein incorporated by reference. Efficiency of antisensesuppression may be increased by including a poly-dT region in theexpression cassette at a position 3′ to the antisense sequence and 5′ ofthe polyadenylation signal. See, US Patent Application PublicationNumber 2002/0048814, herein incorporated by reference.

iii. Double-Stranded RNA Interference

In some embodiments of the invention, inhibition of the expression of aNUE polypeptide may be obtained by double-stranded RNA (dsRNA)interference. For dsRNA interference, a sense RNA molecule like thatdescribed above for cosuppression and an antisense RNA molecule that isfully or partially complementary to the sense RNA molecule are expressedin the same cell, resulting in inhibition of the expression of thecorresponding endogenous messenger RNA.

Expression of the sense and antisense molecules can be accomplished bydesigning the expression cassette to comprise both a sense sequence andan antisense sequence. Alternatively, separate expression cassettes maybe used for the sense and antisense sequences. Multiple plant linestransformed with the dsRNA interference expression cassette orexpression cassettes are then screened to identify plant lines that showthe greatest inhibition of NUE polypeptide expression. Methods for usingdsRNA interference to inhibit the expression of endogenous plant genesare described in Waterhouse, et al., (1998) Proc. Natl. Acad. Sci. USA95:13959-13964, Liu, et al., (2002) Plant Physiol. 129:1732-1743 and WO1999/49029, WO 1999/53050, WO 1999/61631 and WO 2000/49035, each ofwhich is herein incorporated by reference.

iv. Hairpin RNA Interference and Intron-Containing Hairpin RNAInterference

In some embodiments of the invention, inhibition of the expression of aNUE polypeptide may be obtained by hairpin RNA (hpRNA) interference orintron-containing hairpin RNA (ihpRNA) interference. These methods arehighly efficient at inhibiting the expression of endogenous genes. See,Waterhouse and Helliwell, (2003) Nat. Rev. Genet. 4:29-38 and thereferences cited therein.

For hpRNA interference, the expression cassette is designed to expressan RNA molecule that hybridizes with itself to form a hairpin structurethat comprises a single-stranded loop region and a base-paired stem. Thebase-paired stem region comprises a sense sequence corresponding to allor part of the endogenous messenger RNA encoding the gene whoseexpression is to be inhibited and an antisense sequence that is fully orpartially complementary to the sense sequence. Alternatively, thebase-paired stem region may correspond to a portion of a promotersequence controlling expression of the gene to be inhibited. Thus, thebase-paired stem region of the molecule generally determines thespecificity of the RNA interference. hpRNA molecules are highlyefficient at inhibiting the expression of endogenous genes and the RNAinterference they induce is inherited by subsequent generations ofplants. See, for example, Chuang and Meyerowitz, (2000) Proc. Natl.Acad. Sci. USA 97:4985-4990; Stoutjesdijk, et al., (2002) Plant Physiol.129:1723-1731 and Waterhouse and Helliwell, (2003) Nat. Rev. Genet.4:29-38. Methods for using hpRNA interference to inhibit or silence theexpression of genes are described, for example, in Chuang andMeyerowitz, (2000) Proc. Natl. Acad. Sci. USA 97:4985-4990;Stoutjesdijk, et al., (2002) Plant Physiol. 129:1723-1731; Waterhouseand Helliwell, (2003) Nat. Rev. Genet. 4:29-38; Pandolfini et al., BMCBiotechnology 3:7 and US Patent Application Publication Number2003/0175965, each of which is herein incorporated by reference. Atransient assay for the efficiency of hpRNA constructs to silence geneexpression in vivo has been described by Panstruga, et al., (2003) Mol.Biol. Rep. 30:135-140, herein incorporated by reference.

For ihpRNA, the interfering molecules have the same general structure asfor hpRNA, but the RNA molecule additionally comprises an intron that iscapable of being spliced in the cell in which the ihpRNA is expressed.The use of an intron minimizes the size of the loop in the hairpin RNAmolecule following splicing, and this increases the efficiency ofinterference. See, for example, Smith, et al., (2000) Nature407:319-320. In fact, Smith, et al., show 100% suppression of endogenousgene expression using ihpRNA-mediated interference. Methods for usingihpRNA interference to inhibit the expression of endogenous plant genesare described, for example, in Smith, et al., (2000) Nature 407:319-320;Wesley, et al., (2001) Plant J. 27:581-590; Wang and Waterhouse, (2001)Curr. Opin. Plant Biol. 5:146-150; Waterhouse and Helliwell, (2003) Nat.Rev. Genet. 4:29-38; Helliwell and Waterhouse, (2003) Methods 30:289-295and US Patent Application Publication Number 2003/0180945, each of whichis herein incorporated by reference.

The expression cassette for hpRNA interference may also be designed suchthat the sense sequence and the antisense sequence do not correspond toan endogenous RNA. In this embodiment, the sense and antisense sequenceflank a loop sequence that comprises a nucleotide sequence correspondingto all or part of the endogenous messenger RNA of the target gene. Thus,it is the loop region that determines the specificity of the RNAinterference. See, for example, WO 2002/00904; Mette, et al., (2000)EMBO J. 19:5194-5201; Matzke, et al., (2001) Curr. Opin. Genet. Devel.11:221-227; Scheid, et al., (2002) Proc. Natl. Acad. Sci., USA99:13659-13662; Aufsaftz, et al., (2002) Proc. Nat'l. Acad. Sci.99(4):16499-16506; Sijen, et al., Curr. Biol. (2001) 11:436-440), hereinincorporated by reference.

v. Amplicon-Mediated Interference

Amplicon expression cassettes comprise a plant virus-derived sequencethat contains all or part of the target gene but generally not all ofthe genes of the native virus. The viral sequences present in thetranscription product of the expression cassette allow the transcriptionproduct to direct its own replication. The transcripts produced by theamplicon may be either sense or antisense relative to the targetsequence (i.e., the messenger RNA for the NUE polypeptide). Methods ofusing amplicons to inhibit the expression of endogenous plant genes aredescribed, for example, in Angell and Baulcombe, (1997) EMBO J.16:3675-3684, Angell and Baulcombe, (1999) Plant J. 20:357-362 and U.S.Pat. No. 6,646,805, each of which is herein incorporated by reference.

vi. Ribozymes

In some embodiments, the polynucleotide expressed by the expressioncassette of the invention is catalytic RNA or has ribozyme activityspecific for the messenger RNA of the NUE polypeptide. Thus, thepolynucleotide causes the degradation of the endogenous messenger RNA,resulting in reduced expression of the NUE polypeptide. This method isdescribed, for example, in U.S. Pat. No. 4,987,071, herein incorporatedby reference.

vii. Small Interfering RNA or Micro RNA

In some embodiments of the invention, inhibition of the expression of aNUE polypeptide may be obtained by RNA interference by expression of agene encoding a micro RNA (miRNA). miRNAs are regulatory agentsconsisting of about 22 ribonucleotides. miRNA are highly efficient atinhibiting the expression of endogenous genes. See, for example Javier,et al., (2003) Nature 425:257-263, herein incorporated by reference.

For miRNA interference, the expression cassette is designed to expressan RNA molecule that is modeled on an endogenous miRNA gene. The miRNAgene encodes an RNA that forms a hairpin structure containing a22-nucleotide sequence that is complementary to another endogenous gene(target sequence). For suppression of NUE expression, the 22-nucleotidesequence is selected from a NUE transcript sequence and contains 22nucleotides of said NUE sequence in sense orientation and 21 nucleotidesof a corresponding antisense sequence that is complementary to the sensesequence. miRNA molecules are highly efficient at inhibiting theexpression of endogenous genes, and the RNA interference they induce isinherited by subsequent generations of plants.

2. Polypeptide-Based Inhibition of Gene Expression

In one embodiment, the polynucleotide encodes a zinc finger protein thatbinds to a gene encoding a NUE polypeptide, resulting in reducedexpression of the gene. In particular embodiments, the zinc fingerprotein binds to a regulatory region of a NUE gene. In otherembodiments, the zinc finger protein binds to a messenger RNA encoding aNUE polypeptide and prevents its translation. Methods of selecting sitesfor targeting by zinc finger proteins have been described, for example,in U.S. Pat. No. 6,453,242, and methods for using zinc finger proteinsto inhibit the expression of genes in plants are described, for example,in US Patent Application Publication Number 2003/0037355, each of whichis herein incorporated by reference.

3. Polypeptide-Based Inhibition of Protein Activity

In some embodiments of the invention, the polynucleotide encodes anantibody that binds to at least one NUE polypeptide and reduces theenhanced nitrogen utilization activity of the NUE polypeptide. Inanother embodiment, the binding of the antibody results in increasedturnover of the antibody-NUE complex by cellular quality controlmechanisms. The expression of antibodies in plant cells and theinhibition of molecular pathways by expression and binding of antibodiesto proteins in plant cells are well known in the art. See, for example,Conrad and Sonnewald, (2003) Nature Biotech. 21:35-36, incorporatedherein by reference.

4. Gene Disruption

In some embodiments of the present invention, the activity of a NUEpolypeptide is reduced or eliminated by disrupting the gene encoding theNUE polypeptide. The gene encoding the NUE polypeptide may be disruptedby any method known in the art. For example, in one embodiment, the geneis disrupted by transposon tagging. In another embodiment, the gene isdisrupted by mutagenizing plants using random or targeted mutagenesisand selecting for plants that have reduced nitrogen utilizationactivity.

i. Transposon Tagging

In one embodiment of the invention, transposon tagging is used to reduceor eliminate the NUE activity of one or more NUE polypeptide. Transposontagging comprises inserting a transposon within an endogenous NUE geneto reduce or eliminate expression of the NUE polypeptide. “NUE gene” isintended to mean the gene that encodes a NUE polypeptide according tothe invention.

In this embodiment, the expression of one or more NUE polypeptide isreduced or eliminated by inserting a transposon within a regulatoryregion or coding region of the gene encoding the NUE polypeptide. Atransposon that is within an exon, intron, 5′ or 3′ untranslatedsequence, a promoter or any other regulatory sequence of a NUE gene maybe used to reduce or eliminate the expression and/or activity of theencoded NUE polypeptide.

Methods for the transposon tagging of specific genes in plants are wellknown in the art. See, for example, Maes, et al., (1999) Trends PlantSci. 4:90-96; Dharmapuri and Sonti, (1999) FEMS Microbiol. Lett.179:53-59; Meissner, et al., (2000) Plant J. 22:265-274; Phogat, et al.,(2000) J. Biosci. 25:57-63; Walbot, (2000) Curr. Opin. Plant Biol.2:103-107; Gai, et al., (2000) Nucleic Acids Res. 28:94-96; Fitzmaurice,et al., (1999) Genetics 153:1919-1928). In addition, the TUSC processfor selecting Mu insertions in selected genes has been described inBensen, et al., (1995) Plant Cell 7:75-84; Mena, et al., (1996) Science274:1537-1540 and U.S. Pat. No. 5,962,764, each of which is hereinincorporated by reference.

ii. Mutant Plants with Reduced Activity

Additional methods for decreasing or eliminating the expression ofendogenous genes in plants are also known in the art and can besimilarly applied to the instant invention. These methods include otherforms of mutagenesis, such as ethyl methanesulfonate-inducedmutagenesis, deletion mutagenesis and fast neutron deletion mutagenesisused in a reverse genetics sense (with PCR) to identify plant lines inwhich the endogenous gene has been deleted. For examples of thesemethods see, Ohshima, et al., (1998) Virology 243:472-481; Okubara, etal., (1994) Genetics 137:867-874 and Quesada, et al., (2000) Genetics154:421-436, each of which is herein incorporated by reference. Inaddition, a fast and automatable method for screening for chemicallyinduced mutations, TILLING (Targeting Induced Local Lesions In Genomes),using denaturing HPLC or selective endonuclease digestion of selectedPCR products is also applicable to the instant invention. See, McCallum,et al., (2000) Nat. Biotechnol. 18:455-457, herein incorporated byreference.

Mutations that impact gene expression or that interfere with thefunction (enhanced nitrogen utilization activity) of the encoded proteinare well known in the art. Insertional mutations in gene exons usuallyresult in null-mutants. Mutations in conserved residues are particularlyeffective in inhibiting the activity of the encoded protein. Conservedresidues of plant NUE polypeptides suitable for mutagenesis with thegoal to eliminate NUE activity have been described. Such mutants can beisolated according to well-known procedures and mutations in differentNUE loci can be stacked by genetic crossing. See, for example, Gruis, etal., (2002) Plant Cell 14:2863-2882.

In another embodiment of this invention, dominant mutants can be used totrigger RNA silencing due to gene inversion and recombination of aduplicated gene locus. See, for example, Kusaba, et al., (2003) PlantCell 15:1455-1467.

The invention encompasses additional methods for reducing or eliminatingthe activity of one or more NUE polypeptide. Examples of other methodsfor altering or mutating a genomic nucleotide sequence in a plant areknown in the art and include, but are not limited to, the use of RNA:DNAvectors, RNA:DNA mutational vectors, RNA:DNA repair vectors,mixed-duplex oligonucleotides, self-complementary RNA:DNAoligonucleotides and recombinogenic oligonucleobases. Such vectors andmethods of use are known in the art. See, for example, U.S. Pat. Nos.5,565,350; 5,731,181; 5,756,325; 5,760,012; 5,795,972 and 5,871,984,each of which are herein incorporated by reference. See also, WO1998/49350, WO 1999/07865, WO 1999/25821 and Beetham, et al., (1999)Proc. Natl. Acad. Sci. USA 96:8774-8778, each of which is hereinincorporated by reference.

iii. Modulating Nitrogen Utilization Activity

In specific methods, the level and/or activity of a NUE regulator in aplant is decreased by increasing the level or activity of the NUEpolypeptide in the plant. The increased expression of a negativeregulatory molecule may decrease the level of expression of downstreamone or more genes responsible for an improved NUE phenotype.

Methods for increasing the level and/or activity of NUE polypeptides ina plant are discussed elsewhere herein. Briefly, such methods compriseproviding a NUE polypeptide of the invention to a plant and therebyincreasing the level and/or activity of the NUE polypeptide. In otherembodiments, a NUE nucleotide sequence encoding a NUE polypeptide can beprovided by introducing into the plant a polynucleotide comprising a NUEnucleotide sequence of the invention, expressing the NUE sequence,increasing the activity of the NUE polypeptide and thereby decreasingthe number of tissue cells in the plant or plant part. In otherembodiments, the NUE nucleotide construct introduced into the plant isstably incorporated into the genome of the plant.

In other methods, the growth of a plant tissue is increased bydecreasing the level and/or activity of the NUE polypeptide in theplant. Such methods are disclosed in detail elsewhere herein. In onesuch method, a NUE nucleotide sequence is introduced into the plant andexpression of said NUE nucleotide sequence decreases the activity of theNUE polypeptide and thereby increasing the tissue growth in the plant orplant part. In other embodiments, the NUE nucleotide constructintroduced into the plant is stably incorporated into the genome of theplant.

As discussed above, one of skill will recognize the appropriate promoterto use to modulate the level/activity of a NUE in the plant. Exemplarypromoters for this embodiment have been disclosed elsewhere herein.

In other embodiments, such plants have stably incorporated into theirgenome a nucleic acid molecule comprising a NUE nucleotide sequence ofthe invention operably linked to a promoter that drives expression inthe plant cell.

iv. Modulating Root Development

Methods for modulating root development in a plant are provided. By“modulating root development” is intended any alteration in thedevelopment of the plant root when compared to a control plant. Suchalterations in root development include, but are not limited to,alterations in the growth rate of the primary root, the fresh rootweight, the extent of lateral and adventitious root formation, thevasculature system, meristem development or radial expansion.

Methods for modulating root development in a plant are provided. Themethods comprise modulating the level and/or activity of the NUEpolypeptide in the plant. In one method, a NUE sequence of the inventionis provided to the plant. In another method, the NUE nucleotide sequenceis provided by introducing into the plant a polynucleotide comprising aNUE nucleotide sequence of the invention, expressing the NUE sequenceand thereby modifying root development. In still other methods, the NUEnucleotide construct introduced into the plant is stably incorporatedinto the genome of the plant.

In other methods, root development is modulated by altering the level oractivity of the NUE polypeptide in the plant. A change in NUE activitycan result in at least one or more of the following alterations to rootdevelopment, including, but not limited to, alterations in root biomassand length.

As used herein, “root growth” encompasses all aspects of growth of thedifferent parts that make up the root system at different stages of itsdevelopment in both monocotyledonous and dicotyledonous plants. It is tobe understood that enhanced root growth can result from enhanced growthof one or more of its parts including the primary root, lateral roots,adventitious roots, etc.

Methods of measuring such developmental alterations in the root systemare known in the art. See, for example, US Patent ApplicationPublication Number 2003/0074698 and Werner, et al., (2001) PNAS18:10487-10492, both of which are herein incorporated by reference.

As discussed above, one of skill will recognize the appropriate promoterto use to modulate root development in the plant. Exemplary promotersfor this embodiment include constitutive promoters and root-preferredpromoters. Exemplary root-preferred promoters have been disclosedelsewhere herein.

Stimulating root growth and increasing root mass by decreasing theactivity and/or level of the NUE polypeptide also finds use in improvingthe standability of a plant. The term “resistance to lodging” or“standability” refers to the ability of a plant to fix itself to thesoil. For plants with an erect or semi-erect growth habit, this termalso refers to the ability to maintain an upright position under adverse(environmental) conditions. This trait relates to the size, depth andmorphology of the root system. In addition, stimulating root growth andincreasing root mass by altering the level and/or activity of the NUEpolypeptide also finds use in promoting in vitro propagation ofexplants.

Furthermore, higher root biomass production due to NUE activity has adirect effect on the yield and an indirect effect of production ofcompounds produced by root cells or transgenic root cells or cellcultures of said transgenic root cells. One example of an interestingcompound produced in root cultures is shikonin, the yield of which canbe advantageously enhanced by said methods.

Accordingly, the present invention further provides plants havingmodulated root development when compared to the root development of acontrol plant. In some embodiments, the plant of the invention has anincreased level/activity of the NUE polypeptide of the invention and hasenhanced root growth and/or root biomass. In other embodiments, suchplants have stably incorporated into their genome a nucleic acidmolecule comprising a NUE nucleotide sequence of the invention operablylinked to a promoter that drives expression in the plant cell.

v. Modulating Shoot and Leaf Development

Methods are also provided for modulating shoot and leaf development in aplant. By “modulating shoot and/or leaf development” is intended anyalteration in the development of the plant shoot and/or leaf. Suchalterations in shoot and/or leaf development include, but are notlimited to, alterations in shoot meristem development, in leaf number,leaf size, leaf and stem vasculature, internode length and leafsenescence. As used herein, “leaf development” and “shoot development”encompasses all aspects of growth of the different parts that make upthe leaf system and the shoot system, respectively, at different stagesof their development, both in monocotyledonous and dicotyledonousplants. Methods for measuring such developmental alterations in theshoot and leaf system are known in the art. See, for example, Werner, etal., (2001) PNAS 98:10487-10492 and US Patent Application PublicationNumber 2003/0074698, each of which is herein incorporated by reference.

The method for modulating shoot and/or leaf development in a plantcomprises modulating the activity and/or level of a NUE polypeptide ofthe invention. In one embodiment, a NUE sequence of the invention isprovided. In other embodiments, the NUE nucleotide sequence can beprovided by introducing into the plant a polynucleotide comprising a NUEnucleotide sequence of the invention, expressing the NUE sequence andthereby modifying shoot and/or leaf development. In other embodiments,the NUE nucleotide construct introduced into the plant is stablyincorporated into the genome of the plant.

In specific embodiments, shoot or leaf development is modulated byaltering the level and/or activity of the NUE polypeptide in the plant.A change in NUE activity can result in at least one or more of thefollowing alterations in shoot and/or leaf development, including, butnot limited to, changes in leaf number, altered leaf surface, alteredvasculature, internodes and plant growth and alterations in leafsenescence when compared to a control plant.

As discussed above, one of skill will recognize the appropriate promoterto use to modulate shoot and leaf development of the plant. Exemplarypromoters for this embodiment include constitutive promoters,shoot-preferred promoters, shoot meristem-preferred promoters andleaf-preferred promoters. Exemplary promoters have been disclosedelsewhere herein.

Increasing NUE activity and/or level in a plant results in alteredinternodes and growth. Thus, the methods of the invention find use inproducing modified plants. In addition, as discussed above, NUE activityin the plant modulates both root and shoot growth. Thus, the presentinvention further provides methods for altering the root/shoot ratio.Shoot or leaf development can further be modulated by altering the leveland/or activity of the NUE polypeptide in the plant.

Accordingly, the present invention further provides plants havingmodulated shoot and/or leaf development when compared to a controlplant. In some embodiments, the plant of the invention has an increasedlevel/activity of the NUE polypeptide of the invention. In otherembodiments, the plant of the invention has a decreased level/activityof the NUE polypeptide of the invention.

vi. Modulating Reproductive Tissue Development

Methods for modulating reproductive tissue development are provided. Inone embodiment, methods are provided to modulate floral development in aplant. By “modulating floral development” is intended any alteration ina structure of a plant's reproductive tissue as compared to a controlplant in which the activity or level of the NUE polypeptide has not beenmodulated. “Modulating floral development” further includes anyalteration in the timing of the development of a plant's reproductivetissue (i.e., a delayed or an accelerated timing of floral development)when compared to a control plant in which the activity or level of theNUE polypeptide has not been modulated. Macroscopic alterations mayinclude changes in size, shape, number or location of reproductiveorgans, the developmental time period that these structures form or theability to maintain or proceed through the flowering process in times ofenvironmental stress. Microscopic alterations may include changes to thetypes or shapes of cells that make up the reproductive organs.

The method for modulating floral development in a plant comprisesmodulating NUE activity in a plant. In one method, a NUE sequence of theinvention is provided. A NUE nucleotide sequence can be provided byintroducing into the plant a polynucleotide comprising a NUE nucleotidesequence of the invention, expressing the NUE sequence and therebymodifying floral development. In other embodiments, the NUE nucleotideconstruct introduced into the plant is stably incorporated into thegenome of the plant.

In specific methods, floral development is modulated by increasing thelevel or activity of the NUE polypeptide in the plant. A change in NUEactivity can result in at least one or more of the following alterationsin floral development, including, but not limited to, altered flowering,changed number of flowers, modified male sterility and altered seed set,when compared to a control plant. Inducing delayed flowering orinhibiting flowering can be used to enhance yield in forage crops suchas alfalfa. Methods for measuring such developmental alterations infloral development are known in the art. See, for example, Mouradov, etal., (2002) The Plant Cell S111-S130, herein incorporated by reference.

As discussed above, one of skill will recognize the appropriate promoterto use to modulate floral development of the plant. Exemplary promotersfor this embodiment include constitutive promoters, inducible promoters,shoot-preferred promoters and inflorescence-preferred promoters.

In other methods, floral development is modulated by altering the leveland/or activity of the NUE sequence of the invention. Such methods cancomprise introducing a NUE nucleotide sequence into the plant andchanging the activity of the NUE polypeptide. In other methods, the NUEnucleotide construct introduced into the plant is stably incorporatedinto the genome of the plant. Altering expression of the NUE sequence ofthe invention can modulate floral development during periods of stress.Such methods are described elsewhere herein. Accordingly, the presentinvention further provides plants having modulated floral developmentwhen compared to the floral development of a control plant. Compositionsinclude plants having an altered level/activity of the NUE polypeptideof the invention and having an altered floral development. Compositionsalso include plants having a modified level/activity of the NUEpolypeptide of the invention wherein the plant maintains or proceedsthrough the flowering process in times of stress.

Methods are also provided for the use of the NUE sequences of theinvention to increase seed size and/or weight. The method comprisesincreasing the activity of the NUE sequences in a plant or plant part,such as the seed. An increase in seed size and/or weight comprises anincreased size or weight of the seed and/or an increase in the size orweight of one or more seed part including, for example, the embryo,endosperm, seed coat, aleurone or cotyledon.

As discussed above, one of skill will recognize the appropriate promoterto use to increase seed size and/or seed weight. Exemplary promoters ofthis embodiment include constitutive promoters, inducible promoters,seed-preferred promoters, embryo-preferred promoters andendosperm-preferred promoters.

The method for altering seed size and/or seed weight in a plantcomprises increasing NUE activity in the plant. In one embodiment, theNUE nucleotide sequence can be provided by introducing into the plant apolynucleotide comprising a NUE nucleotide sequence of the invention,expressing the NUE sequence and thereby decreasing seed weight and/orsize. In other embodiments, the NUE nucleotide construct introduced intothe plant is stably incorporated into the genome of the plant.

It is further recognized that increasing seed size and/or weight canalso be accompanied by an increase in the speed of growth of seedlingsor an increase in early vigor. As used herein, the term “early vigor”refers to the ability of a plant to grow rapidly during earlydevelopment, and relates to the successful establishment, aftergermination, of a well-developed root system and a well-developedphotosynthetic apparatus. In addition, an increase in seed size and/orweight can also result in an increase in plant yield when compared to acontrol.

Accordingly, the present invention further provides plants having anincreased seed weight and/or seed size when compared to a control plant.In other embodiments, plants having an increased vigor and plant yieldare also provided. In some embodiments, the plant of the invention has amodified level/activity of the NUE polypeptide of the invention and hasan increased seed weight and/or seed size. In other embodiments, suchplants have stably incorporated into their genome a nucleic acidmolecule comprising a NUE nucleotide sequence of the invention operablylinked to a promoter that drives expression in the plant cell.

vii. Method of Use for NUE Polynucleotide, Expression Cassettes, andAdditional Polynucleotides

The nucleotides, expression cassettes and methods disclosed herein areuseful in regulating expression of any heterologous nucleotide sequencein a host plant in order to vary the phenotype of a plant. Variouschanges in phenotype are of interest including modifying the fatty acidcomposition in a plant, altering the amino acid content of a plant,altering a plant's pathogen defense mechanism and the like. Theseresults can be achieved by providing expression of heterologous productsor increased expression of endogenous products in plants. Alternatively,the results can be achieved by providing for a reduction of expressionof one or more endogenous products, particularly enzymes or cofactors inthe plant. These changes result in a change in phenotype of thetransformed plant.

Genes of interest are reflective of the commercial markets and interestsof those involved in the development of the crop. Crops and markets ofinterest change, and as developing nations open up world markets, newcrops and technologies will emerge also. In addition, as ourunderstanding of agronomic traits and characteristics such as yield andheterosis increase, the choice of genes for transformation will changeaccordingly. General categories of genes of interest include, forexample, those genes involved in information, such as zinc fingers,those involved in communication, such as kinases, and those involved inhousekeeping, such as heat shock proteins. More specific categories oftransgenes, for example, include genes encoding important traits foragronomics, insect resistance, disease resistance, herbicide resistance,sterility, grain characteristics and commercial products. Genes ofinterest include, generally, those involved in oil, starch, carbohydrateor nutrient metabolism as well as those affecting kernel size, sucroseloading and the like.

In certain embodiments the nucleic acid sequences of the presentinvention can be used in combination (“stacked”) with otherpolynucleotide sequences of interest in order to create plants with adesired phenotype. The combinations generated can include multiplecopies of any one or more of the polynucleotides of interest. Thepolynucleotides of the present invention may be stacked with any gene orcombination of genes to produce plants with a variety of desired traitcombinations, including but not limited to traits desirable for animalfeed such as high oil genes (e.g., U.S. Pat. No. 6,232,529); balancedamino acids (e.g., hordothionins (U.S. Pat. Nos. 5,990,389; 5,885,801;5,885,802 and 5,703,409); barley high lysine (Williamson, et al., (1987)Eur. J. Biochem. 165:99-106 and WO 1998/20122) and high methionineproteins (Pedersen, et al., (1986) J. Biol. Chem. 261:6279; Kirihara, etal., (1988) Gene 71:359 and Musumura, et al., (1989) Plant Mol. Biol.12:123)); increased digestibility (e.g., modified storage proteins (U.S.patent application Ser. No. 10/053,410, filed Nov. 7, 2001) andthioredoxins (U.S. patent application Ser. No. 10/005,429, filed Dec. 3,2001)), the disclosures of which are herein incorporated by reference.The polynucleotides of the present invention can also be stacked withtraits desirable for insect, disease or herbicide resistance (e.g.,Bacillus thuringiensis toxic proteins (U.S. Pat. Nos. 5,366,892;5,747,450; 5,737,514; 5,723,756; 5,593,881; Geiser, et al., (1986) Gene48:109); lectins (Van Damme, et al., (1994) Plant Mol. Biol. 24:825);fumonisin detoxification genes (U.S. Pat. No. 5,792,931); avirulence anddisease resistance genes (Jones, et al., (1994) Science 266:789; Martin,et al., (1993) Science 262:1432; Mindrinos, et al., (1994) Cell78:1089); acetolactate synthase (ALS) mutants that lead to herbicideresistance such as the S4 and/or Hra mutations; inhibitors of glutaminesynthase such as phosphinothricin or basta (e.g., bar gene); andglyphosate resistance (EPSPS gene)) and traits desirable for processingor process products such as high oil (e.g., U.S. Pat. No. 6,232,529);modified oils (e.g., fatty acid desaturase genes (U.S. Pat. No.5,952,544; WO 1994/11516)); modified starches (e.g., ADPGpyrophosphorylases (AGPase), starch synthases (SS), starch branchingenzymes (SBE) and starch debranching enzymes (SDBE)) and polymers orbioplastics (e.g., U.S. Pat. No. 5,602,321; beta-ketothiolase,polyhydroxybutyrate synthase, and acetoacetyl-CoA reductase (Schubert,et al., (1988) J. Bacteriol. 170:5837-5847) facilitate expression ofpolyhydroxyalkanoates (PHAs)), the disclosures of which are hereinincorporated by reference. One could also combine the polynucleotides ofthe present invention with polynucleotides affecting agronomic traitssuch as male sterility (e.g., see, U.S. Pat. No. 5,583,210), stalkstrength, flowering time, or transformation technology traits such ascell cycle regulation or gene targeting (e.g., WO 1999/61619; WO2000/17364; WO 1999/25821), the disclosures of which are hereinincorporated by reference.

In one embodiment, sequences of interest improve plant growth and/orcrop yields. For example, sequences of interest include agronomicallyimportant genes that result in improved primary or lateral root systems.Such genes include, but are not limited to, nutrient/water transportersand growth induces. Examples of such genes, include but are not limitedto, maize plasma membrane H⁺-ATPase (MHA2) (Frias, et al., (1996) PlantCell 8:1533-44); AKT1, a component of the potassium uptake apparatus inArabidopsis, (Spalding, et al., (1999) J Gen Physiol 113:909-18); RMLgenes which activate cell division cycle in the root apical cells(Cheng, et al., (1995) Plant Physiol 108:881); maize glutaminesynthetase genes (Sukanya, et al., (1994) Plant Mol Biol 26:1935-46) andhemoglobin (Duff, et al., (1997) J. Biol. Chem. 27:16749-16752,Arredondo-Peter, et al., (1997) Plant Physiol. 115:1259-1266;Arredondo-Peter, et al., (1997) Plant Physiol 114:493-500 and referencessited therein). The sequence of interest may also be useful inexpressing antisense nucleotide sequences of genes that that negativelyaffects root development.

Additional, agronomically important traits such as oil, starch andprotein content can be genetically altered in addition to usingtraditional breeding methods. Modifications include increasing contentof oleic acid, saturated and unsaturated oils, increasing levels oflysine and sulfur, providing essential amino acids and also modificationof starch. Hordothionin protein modifications are described in U.S. Pat.Nos. 5,703,049, 5,885,801, 5,885,802 and 5,990,389, herein incorporatedby reference. Another example is lysine and/or sulfur rich seed proteinencoded by the soybean 2S albumin described in U.S. Pat. No. 5,850,016and the chymotrypsin inhibitor from barley described in Williamson, etal., (1987) Eur. J. Biochem. 165:99-106, the disclosures of which areherein incorporated by reference.

Derivatives of the coding sequences can be made by site-directedmutagenesis to increase the level of preselected amino acids in theencoded polypeptide. For example, the gene encoding the barley highlysine polypeptide (BHL) is derived from barley chymotrypsin inhibitor,U.S. patent application Ser. No. 08/740,682, filed Nov. 1, 1996, and WO1998/20133, the disclosures of which are herein incorporated byreference. Other proteins include methionine-rich plant proteins such asfrom sunflower seed (Lilley, et al., (1989) Proceedings of the WorldCongress on Vegetable Protein Utilization in Human Foods and AnimalFeedstuffs, ed. Applewhite (American Oil Chemists Society, Champaign,Ill.), pp. 497-502; herein incorporated by reference); corn (Pedersen,et al., (1986) J. Biol. Chem. 261:6279; Kirihara, et al., (1988) Gene71:359, both of which are herein incorporated by reference) and rice(Musumura, et al., (1989) Plant Mol. Biol. 12:123, herein incorporatedby reference). Other agronomically important genes encode latex, Floury2, growth factors, seed storage factors and transcription factors.

Insect resistance genes may encode resistance to pests that have greatyield drag such as rootworm, cutworm, European Corn Borer and the like.Such genes include, for example, Bacillus thuringiensis toxic proteingenes (U.S. Pat. Nos. 5,366,892; 5,747,450; 5,736,514; 5,723,756;5,593,881 and Geiser, et al., (1986) Gene 48:109) and the like.

Genes encoding disease resistance traits include detoxification genes,such as against fumonosin (U.S. Pat. No. 5,792,931); avirulence (avr)and disease resistance (R) genes (Jones, et al., (1994) Science 266:789;Martin, et al., (1993) Science 262:1432 and Mindrinos, et al., (1994)Cell 78:1089) and the like.

Herbicide resistance traits may include genes coding for resistance toherbicides that act to inhibit the action of acetolactate synthase(ALS), in particular the sulfonylurea-type herbicides (e.g., theacetolactate synthase (ALS) gene containing mutations leading to suchresistance, in particular the S4 and/or Hra mutations), genes coding forresistance to herbicides that act to inhibit action of glutaminesynthase, such as phosphinothricin or basta (e.g., the bar gene) orother such genes known in the art. The bar gene encodes resistance tothe herbicide basta, the nptII gene encodes resistance to theantibiotics kanamycin and geneticin and the ALS-gene mutants encoderesistance to the herbicide chlorsulfuron.

Sterility genes can also be encoded in an expression cassette andprovide an alternative to physical detasseling. Examples of genes usedin such ways include male tissue-preferred genes and genes with malesterility phenotypes such as QM, described in U.S. Pat. No. 5,583,210.Other genes include kinases and those encoding compounds toxic to eithermale or female gametophytic development.

The quality of grain is reflected in traits such as levels and types ofoils, saturated and unsaturated, quality and quantity of essential aminoacids, and levels of cellulose. In corn, modified hordothionin proteinsare described in U.S. Pat. Nos. 5,703,049, 5,885,801, 5,885,802 and5,990,389.

Commercial traits can also be encoded on a gene or genes that couldincrease for example, starch for ethanol production or provideexpression of proteins. Another important commercial use of transformedplants is the production of polymers and bioplastics such as describedin U.S. Pat. No. 5,602,321. Genes such as β-Ketothiolase, PHBase(polyhydroxyburyrate synthase) and acetoacetyl-CoA reductase (see,Schubert, et al., (1988) J. Bacteriol. 170:5837-5847) facilitateexpression of polyhyroxyalkanoates (PHAs).

Exogenous products include plant enzymes and products as well as thosefrom other sources including procaryotes and other eukaryotes. Suchproducts include enzymes, cofactors, hormones and the like. The level ofproteins, particularly modified proteins having improved amino aciddistribution to improve the nutrient value of the plant, can beincreased. This is achieved by the expression of such proteins havingenhanced amino acid content.

This invention can be better understood by reference to the followingnon-limiting examples. It will be appreciated by those skilled in theart that other embodiments of the invention may be practiced withoutdeparting from the spirit and the scope of the invention as hereindisclosed and claimed.

EXAMPLES Example 1 Isolation of NUE Sequences

A routine for identifying all members of a gene family can be employedto search for the enhanced nitrogen utilization efficiency genes ofinterest. A diverse set of all the known members of the gene family asprotein sequences would be prepared. This data includes sequences fromother species. These species are then searched against a proprietarymaize sequence dataset and a nonredundant set of overlapping hits isidentified. Separately, one takes the nucleotide sequences of any genesof interest in hand and searches against the database and a nonredundantset of all overlapping hits are retrieved. The set of protein hits arethen compared to the nucleotide hits. If the gene family is complete,all of the protein hits are contained within the nucleotide hits.

Example 2 Categorization of NUE by Function

TABLE 1 SEQ ID NOS: Gene Description Functional Grouping NA/AA Zincfinger transcription factor Transcription Factor  1/2 MADS-domainTranscription Factor  3/4 transcription factor Myb-related transcriptionfactor Transcription Factor  5/6 MADS-domain Transcription Factor  7/8transcription factor Protein kinase Signal Transduction  9/10 NitricOxidase Synthase Signal Transduction  11/12 Ferredoxin-NADP + reductaseNitrogen-Carbon Assimilation  13/14 Ferredoxin—nitrate redutaseNitrogen-Carbon Assimilation  15/16 B-type cyclin Miscellaneous orunknown  17/18 function RING-H2 finger protein Signal Transduction 19/20 Ferrredoxin—nitrate reducatse Nitrogen-Carbon Assimilation  21/22Glycine decarboxylase Amino acid metabolism  23/24 complex H-proteinUnknown or Hypothetical Miscellaneous or unknown  25/26 (Conserved)Protein function Transketolase Metabolic Enzyme  27/28 FerredoxinNitrogen-Carbon Assimilation  29/30 Hydrolase Metabolic Enzyme  31/32Unknown or Hypothetical Miscellaneous or unknown  33/34 (Conserved)Protein function Serine/threonine kinase Signal Transduction  35/36Unknown or Hypothetical Miscellaneous or unknown  37/38 (Conserved)Protein function Vacuolar H+−exporting ATPase Transporter  39/40 Unknownor Hypothetical Miscellaneous or unknown  41/42 (Conserved) Proteinfunction Putative monodehydroascorbate Stress and Hormone Response 43/44 reductase Homeodomain leucine Transcription Factor  45/46 zipperprotein 3-isopropylmalate dehydratase Metabolic Enzyme  47/48 largesubunit Unknown or Hypothetical Miscellaneous or unknown  49/50(Conserved) Protein function Polyamine oxidase Stress and HormoneResponse  51/52 Unknown or Hypothetical Miscellaneous or unknown  53/54(Conserved) Protein function Arginine N-methyltransferase Amino acidmetabolism  55/56 Putative succinyl-CoA ligase Metabolic Enzyme  57/58alpha subunit Asparagine synthasetase Amino acid metabolism  59/60Ferredoxin Nitrogen-Carbon Assimilation  61/62 tRNA synthetase class IIMetabolic Enzyme  63/64 (G, H, P and S) family protein Putative HB2homeodomain Transcription Factor  65/66 protein EREBP-like proteinTranscription Factor  67/68 Aspartate carbamoyl transferase Amino acidmetabolism  69/70 Putative amino acid transport Transporter  71/72N-carbamyl-L-amino acid Amino acid metabolism  73/74 amidohydrolaseMitochondrial malate Metabolic Enzyme  75/76 dehvdrogenaseAdenosylhomocysteinase- Metabolic Enzyme  77/78 like proteinEndonuclease/exonuclease/ Metabolic Enzyme  79/80 phosphatase familyprotein-like Rapamycin-binding protein Miscellaneous or unknown  81/82function Putative leucine-rich receptor- Signal Transduction  83/84 likeprotein kinase Unknown or Hypothetical Miscellaneous or unknown  85/86(Conserved) Protein function Unknown or Hypothetical Miscellaneous orunknown  87/88 (Conserved) Protein function Pathogenesis related proteinStress and Hormone Response  89/90 Peptide transport protein Transporter 91/92 Ferredoxin Nitrogen-Carbon Assimilation  93/94 Aminoacylase Aminoacid metabolism  95/96 PDR-type ABC transporter-like Transporter  97/98Unknown or Hypothetical Miscellaneous or unknown  99/100 (Conserved)Protein function DRE binding factor 2 Miscellaneous or unknown 101/102function Glycine Amino acid metabolism 103/104 hydroxymethyltransferaseDentin sialophosphoprotein Miscellaneous or unknown 105/106precursor-like protein function ATP-citrate synthase Metabolic Enzyme107/108 Gamma-lyase Metabolic Enzyme 109/110 Unknown or HypotheticalMiscellaneous or unknown 111/112 (Conserved) Protein function Unknown orHypothetical Miscellaneous or unknown 113/114 (Conserved) Proteinfunction Unknown or Hypothetical Miscellaneous or unknown 115/116(Conserved) Protein function Unknown or Hypothetical Miscellaneous orunknown 117/118 (Conserved) Protein function Unknown or HypotheticalMiscellaneous or unknown 119/120 (Conserved) Protein function Histidineamino acid transporter Transporter 121/122 NOD26-like membrane integralTransporter 123/124 protein ZmNIP2-2 Glucose-6-phosphate/phosphate-Transporter 125/126 translocator precursor Lipoxygenase Stress andHormone Response 127/128 Homocysteine Stress and Hormone Response129/130 S-methyltransferase Ferredoxin Nitrogen-Carbon Assimilation131/132 Ferredoxin-dependent glutamate Nitrogen-Carbon Assimilation133/134 synthase, chloroplast Glutamine synthase Nitrogen-CarbonAssimilation 135/136 Glutamine synthase Nitrogen-Carbon Assimilation137/138 Cytoskeletal protein Miscellaneous or unknown 139/140 functionOCL3 protein Miscellaneous or unknown 141/142 function Seven in absentiaMiscellaneous or unknown 143/144 function Copper chaperone Miscellaneousor unknown 145/146 function Branched-chain amino acid Amino acidmetabolism 147/148 aminotransferase Glutamate dehydrogenase Amino acidmetabolism 149/150 Hydroxyanthranilate Amino acid metabolism 151/152hydroxycinnamoyltransferase Alanine aminotransferase Amino acidmetabolism 153/154 Tryptophan synthase Amino acid metabolism 155/156Putative aspartate Amino acid metabolism 157/158 aminotransferaseUroporphyrin-III Metabolic Enzyme 159/160 C-methyltransferase Unknown orHypothetical Miscellaneous or unknown 161/162 (Conserved) Proteinfunction ATP-dependent transporter Transporter 163/164 PermeaseTransporter 165/166 ABA-responsive protein Stress and Hormone Response167/168 GTPase activating protein-like Stress and Hormone Response169/170 Lypoxygenase Stress and Hormone Response 171/172 FerredoxinNitrogen-Carbon Assimilation 173/174 Fd III Nitrogen-Carbon Assimilation175/176 Nitrate reductase Nitrogen-Carbon Assimilation 177/178NADP-specific isocitrate Miscellaneous or unknown 179/180 dehydrogenasefunction Nucleic acid binding protein Miscellaneous or unknown 181/182function Arginine N-methyltransferase Amino acid metabolism 183/184Lysine decarboxylase-like protein Amino acid metabolism 185/186Glutamate decarboxylase isozyme Amino acid metabolism 187/188 Argininedecarboxylase (ADC) Amino acid metabolism 189/190 Arginine decarboxylase(ADC) Amino acid metabolism 191/192 MATE efflux family proteinTransporter 193/194 Putative nitrate transporter Transporter 195/196Oligopeptide transporter OPT-like Transporter 197/198 Ammoniumtransporter Transporter 199/200 Amino acid transport Transporter 201/202protein AAP1 Putative oligopeptide transporter Transporter 203/204 NACTranscription factor Transcription Factor 205/206 Myb transcriptionfactor Transcription Factor 207/208 MADS-domain transcriptionTranscription Factor 209/210 factor Abscisic acid- and stress- Stressand Hormone Response 211/212 inducible protein Trehalose-6-phosphatesynthase Stress and Hormone Response 213/214 F-box protein; coronatine-Signal Transduction 215/216 insensitive 1/COL1 (FBL2) Alanineaminotransferase Amino acid metabolism 217/218 Putative sulfatetransporter Transporter 219/220 Nitrate transporter, putativeTransporter 221/222 Ethylene-responsive element Transcription Factor223/224 binding factor Unknown; WRKY Miscellaneous or unknown 225/226transcription factor? function Ethylene-responsive element TransductionFactor 227/228 binding factor Ser-Thr Protein Kinase Signal Transduction229/230 Leucine-rich repeat family Signal Transduction 231/232protein/protein kinase family protein Putative IAA-amino acid Stress andHormone Response 233/234 hydrolase Carbon-nitrogen hydrolaseNitrogen-Carbon Assimilation 235/236 family protein Glutamine synthaseNitrogen-Carbon Assimilation 237/238 Glutamine synthase Nitrogen-CarbonAssimilation 239/240 Drought-induced Stress and Hormone Response 241/242hydrophobic protein Amino acid transporter Transporter 243/244Diacylglycerol kinase Metabolic Enzyme 245/246 Nitrite reductaseNitrogen-Carbon Assimilation 247/248 Putative potassium transporterTransporter 249/250 Putative sugar transporter Transporter 251/252S-adenosylmethionine Stress and Hormone Response 253/254 decarboxylaseTA1 protein-like Miscellaneous or unknown 255/256 function Unknown orHypothetical Miscellaneous or unknown 257/258 (Conserved) Proteinfunction glutamate decarboxylase Amino acid metabolism 259/260Aminotransferase Amino acid metabolism 261/262 Alanine aminotransferaseAmino acid metabolism 263/264 Diphthamide synthesis Miscellaneous orunknown 265/266 DPH2-like function Unknown or Hypothetical Miscellaneousor unknown 267/268 (Conserved) Protein function Unknown or HypotheticalMiscellaneous or unknown 269/270 (Conserved) Protein fuction Unknown orHypothetical Miscellaneous or unknown 271/272 (Conserved) Proteinfunction Hydrolase Metabolic Enzyme 273/274 Alliinase Miscellaneous orunknown 275/276 function Molybdenum cofactor Nitrogen-CarbonAssimilation 277/278 synthesis protein 3 Unknown or HypotheticalMiscellaneous or unknown 279/280 (Conserved) Protein function Unknown orHypothetical Miscellaneous or unknown 281/282 (Conserved) Proteinfunction Acylaminoacyl-peptidase Metabolic Enzyme 283/284 Serinepalmitoyltransferase Amino acid metabolism 285/286 Unknown orHypothetical Miscellaneous or unknown 287/288 (Conserved) Proteinfunction Unknown or Hypothetical Miscellaneous or unknown 289/290(Conserved) Protein function Permease Transporter 291/292 Amino acidpermease Transporter 293/294 Putative early nodulin Miscellaneous orunknown 295/296 function Nitrilase 1 Miscellaneous or unknown 297/298function Putative 3-isopropylmalate Metabolic Enzyme 299/300dehydrogenase Glutamine synthetase Nitrogen-Carbon Assimilation 301/302S-adenosylmethionine Stress and Hormone Response 303/304 decarboxylaseABSCISIC STRESS Stress and Hormone Response 305/306 RIPENING PROTEIN 3Uroporphyrin-III Miscellaneous or unknown 307/308 C-methyltransferasefunction Metallopeptidase Metabolic Enzyme 309/310 Prolyl aminopeptidaseAmino acid metabolism 311/312 Root-specific metal transporterTransporter 313/314

Example 3 Expression Patterns in Maize Using MPSS

MPSS stands for Massively Parallel Signature Sequencing, a techniqueinvented and commercialized by Lynx Therapeutics, Inc. of Hayward,Calif. MPSS and related technologies have been described in publicationsby Brenner, et al., (Nature Biotechnol. (2000) 18:630-634 and PNAS(2000) 97:1665-1670). Like SAGE (Serial Analysis of Gene Expression),MPSS produces short sequence signatures produced from a defined positionwithin an mRNA and the relative abundance of these signatures in a givenlibrary represents a quantitative estimate of expression of that gene.The MPSS signatures are 17 bp in length, and can uniquely identify >95%of all genes in Arabidopsis.

The NUE sequences were matched to MPSS data, and matching tags(GATC-17mers) were curated. Ideally, the correct tag for a gene is inthe plus strand proximal to but just up from the poly A tail and it isgene specific. Where more than one tag matches a gene, one will usuallychoose the one closest to the poly A tail, which is also usually the onewith the highest gene expression. Where the tag matches more than onegene, the correct gene association is usually the one that has an ESTdistribution that best corresponds to the expression pattern revealed bythe MPSS data.

Example 4 Transformation and Regeneration of Transgenic Plants

Immature maize embryos from greenhouse donor plants are bombarded with aplasmid containing the NUE sequence operably linked to thedrought-inducible promoter RAB17 promoter (Vilardell, et al., (1990)Plant Mol Biol 14:423-432) and the selectable marker gene PAT, whichconfers resistance to the herbicide Bialaphos. Alternatively, theselectable marker gene is provided on a separate plasmid. Transformationis performed as follows. Media recipes follow below.

Preparation of Target Tissue:

The ears are husked and surface sterilized in 30% Clorox® bleach plus0.5% Micro detergent for 20 minutes and rinsed two times with sterilewater. The immature embryos are excised and placed embryo axis side down(scutellum side up), 25 embryos per plate, on 560Y medium for 4 hoursand then aligned within the 2.5-cm target zone in preparation forbombardment.

Preparation of DNA:

A plasmid vector comprising the NUE sequence operably linked to anubiquitin promoter is made. This plasmid DNA plus plasmid DNA containinga PAT selectable marker is precipitated onto 1.1 μm (average diameter)tungsten pellets using a CaCl₂ precipitation procedure as follows:

-   -   100 μl prepared tungsten particles in water    -   10 μl (1 μg) DNA in Tris EDTA buffer (1 μg total DNA)    -   100 μl 2.5 M CaCl₂    -   10 μl 0.1 M spermidine

Each reagent is added sequentially to the tungsten particle suspension,while maintained on the multitube vortexer. The final mixture issonicated briefly and allowed to incubate under constant vortexing for10 minutes. After the precipitation period, the tubes are centrifugedbriefly, liquid removed, washed with 500 ml 100% ethanol and centrifugedfor 30 seconds. Again the liquid is removed, and 105 μl 100% ethanol isadded to the final tungsten particle pellet. For particle gunbombardment, the tungsten/DNA particles are briefly sonicated and 10 μlspotted onto the center of each macrocarrier and allowed to dry about 2minutes before bombardment.

Particle Gun Treatment:

The sample plates are bombarded at level #4 in a particle gun. Allsamples receive a single shot at 650 PSI, with a total of ten aliquotstaken from each tube of prepared particles/DNA.

Subsequent Treatment:

Following bombardment, the embryos are kept on 560Y medium for 2 days,then transferred to 560R selection medium containing 3 mg/literBialaphos and subcultured every 2 weeks. After approximately 10 weeks ofselection, selection-resistant callus clones are transferred to 288Jmedium to initiate plant regeneration. Following somatic embryomaturation (2-4 weeks), well-developed somatic embryos are transferredto medium for germination and transferred to the lighted culture room.Approximately 7-10 days later, developing plantlets are transferred to272V hormone-free medium in tubes for 7-10 days until plantlets are wellestablished. Plants are then transferred to inserts in flats (equivalentto 2.5″ pot) containing potting soil and grown for 1 week in a growthchamber, subsequently grown an additional 1-2 weeks in the greenhouse,then transferred to classic 600 pots (1.6 gallon) and grown to maturity.Plants are monitored and scored for increased drought tolerance. Assaysto measure improved drought tolerance are routine in the art andinclude, for example, increased kernel-earring capacity yields underdrought conditions when compared to control maize plants under identicalenvironmental conditions. Alternatively, the transformed plants can bemonitored for a modulation in meristem development (i.e., a decrease inspikelet formation on the ear). See, for example, Bruce, et al., (2002)Journal of Experimental Botany 53:1-13.

Bombardment and Culture Media:

Bombardment medium (560Y) comprises 4.0 g/l N6 basal salts (SIGMAC-1416), 1.0 ml/I Eriksson's Vitamin Mix (1000×SIGMA-1511), 0.5 mg/lthiamine HCl, 120.0 g/l sucrose, 1.0 mg/l 2,4-D and 2.88 g/l L-proline(brought to volume with D-I H₂O following adjustment to pH 5.8 withKOH); 2.0 g/l Gelrite® (added after bringing to volume with D-I H₂O) and8.5 mg/l silver nitrate (added after sterilizing the medium and coolingto room temperature). Selection medium (560R) comprises 4.0 g/l N6 basalsalts (SIGMA C-1416), 1.0 ml/I Eriksson's Vitamin Mix (1000×SIGMA-1511),0.5 mg/l thiamine HCl, 30.0 g/l sucrose and 2.0 mg/l 2,4-D (brought tovolume with D-I H₂O following adjustment to pH 5.8 with KOH); 3.0 g/lGelrite® (added after bringing to volume with D-I H₂O) and 0.85 mg/lsilver nitrate and 3.0 mg/l bialaphos (both added after sterilizing themedium and cooling to room temperature).

Plant regeneration medium (288J) comprises 4.3 g/l MS salts (GIBCO11117-074), 5.0 ml/I MS vitamins stock solution (0.100 g nicotinic acid,0.02 g/l thiamine HCL, 0.10 g/l pyridoxine HCL and 0.40 g/l glycinebrought to volume with polished D-I H₂O) (Murashige and Skoog, (1962)Physiol. Plant. 15:473), 100 mg/l myo-inositol, 0.5 mg/l zeatin, 60 g/lsucrose, and 1.0 ml/I of 0.1 mM abscisic acid (brought to volume withpolished D-I H₂O after adjusting to pH 5.6); 3.0 g/l Gelrite® (addedafter bringing to volume with D-I H₂O) and 1.0 mg/l indoleacetic acidand 3.0 mg/l bialaphos (added after sterilizing the medium and coolingto 60° C.). Hormone-free medium (272V) comprises 4.3 g/l MS salts (GIBCO11117-074), 5.0 ml/I MS vitamins stock solution (0.100 g/l nicotinicacid, 0.02 g/l thiamine HCL, 0.10 g/l pyridoxine HCL and 0.40 g/lglycine brought to volume with polished D-I H₂O), 0.1 g/l myo-inositoland 40.0 g/l sucrose (brought to volume with polished D-I H₂O afteradjusting pH to 5.6) and 6 g/l Bacto™-agar (added after bringing tovolume with polished D-I H₂O), sterilized and cooled to 60° C.

Example 5 Agrobacterium-Mediated Transformation

For Agrobacterium-mediated transformation of maize with an antisensesequence of the NUE sequence of the present invention, preferably themethod of Zhao is employed (U.S. Pat. No. 5,981,840 and PCT PatentApplication Publication Number WO 1998/32326, the contents of which arehereby incorporated by reference). Briefly, immature embryos areisolated from maize and the embryos contacted with a suspension ofAgrobacterium, where the bacteria are capable of transferring theantisense NUE sequences to at least one cell of at least one of theimmature embryos (step 1: the infection step). In this step the immatureembryos are preferably immersed in an Agrobacterium suspension for theinitiation of inoculation. The embryos are co-cultured for a time withthe Agrobacterium (step 2: the co-cultivation step). Preferably theimmature embryos are cultured on solid medium following the infectionstep. Following this co-cultivation period an optional “resting” step iscontemplated. In this resting step, the embryos are incubated in thepresence of at least one antibiotic known to inhibit the growth ofAgrobacterium without the addition of a selective agent for planttransformants (step 3: resting step). Preferably the immature embryosare cultured on solid medium with antibiotic, but without a selectingagent, for elimination of Agrobacterium and for a resting phase for theinfected cells. Next, inoculated embryos are cultured on mediumcontaining a selective agent and growing transformed callus is recovered(step 4: the selection step). Preferably, the immature embryos arecultured on solid medium with a selective agent resulting in theselective growth of transformed cells. The callus is then regeneratedinto plants (step 5: the regeneration step) and preferably calli grownon selective medium are cultured on solid medium to regenerate theplants. Plants are monitored and scored for a modulation in meristemdevelopment. For instance, alterations of size and appearance of theshoot and floral meristems and/or increased yields of leaves, flowersand/or fruits.

Example 6 Soybean Embryo Transformation

Soybean embryos are bombarded with a plasmid containing an antisense NUEsequences operably linked to an ubiquitin promoter as follows. To inducesomatic embryos, cotyledons, 3-5 mm in length dissected fromsurface-sterilized, immature seeds of the soybean cultivar A2872, arecultured in the light or dark at 26° C. on an appropriate agar mediumfor six to ten weeks. Somatic embryos producing secondary embryos arethen excised and placed into a suitable liquid medium. After repeatedselection for clusters of somatic embryos that multiplied as early,globular-staged embryos, the suspensions are maintained as describedbelow.

Soybean embryogenic suspension cultures can be maintained in 35 mlliquid media on a rotary shaker, 150 rpm, at 26° C. with florescentlights on a 16:8 hour day/night schedule. Cultures are subcultured everytwo weeks by inoculating approximately 35 mg of tissue into 35 ml ofliquid medium.

Soybean embryogenic suspension cultures may then be transformed by themethod of particle gun bombardment (Klein, et al., (1987) Nature(London) 327:70-73, U.S. Pat. No. 4,945,050). A Du Pont BiolisticPDS1000/HE instrument (helium retrofit) can be used for thesetransformations.

A selectable marker gene that can be used to facilitate soybeantransformation is a transgene composed of the 35S promoter fromCauliflower Mosaic Virus (Odell, et al., (1985) Nature 313:810-812), thehygromycin phosphotransferase gene from plasmid pJR225 (from E. coli;Gritz, et al., (1983) Gene 25:179-188) and the 3′ region of the nopalinesynthase gene from the T-DNA of the Ti plasmid of Agrobacteriumtumefaciens. The expression cassette comprising an antisense NUEsequence operably linked to the ubiquitin promoter can be isolated as arestriction fragment. This fragment can then be inserted into a uniquerestriction site of the vector carrying the marker gene.

To 50 μl of a 60 mg/ml 1 μm gold particle suspension is added (inorder): 5 μl DNA (1 μg/μl), 20 μl spermidine (0.1 M) and 50 μl CaCl₂(2.5 M). The particle preparation is then agitated for three minutes,spun in a microfuge for 10 seconds and the supernatant removed. TheDNA-coated particles are then washed once in 400 μl 70% ethanol andresuspended in 40 μl of anhydrous ethanol. The DNA/particle suspensioncan be sonicated three times for one second each. Five microliters ofthe DNA-coated gold particles are then loaded on each macro carrierdisk.

Approximately 300-400 mg of a two-week-old suspension culture is placedin an empty 60×15 mm petri dish and the residual liquid removed from thetissue with a pipette. For each transformation experiment, approximately5-10 plates of tissue are normally bombarded. Membrane rupture pressureis set at 1100 psi and the chamber is evacuated to a vacuum of 28 inchesmercury. The tissue is placed approximately 3.5 inches away from theretaining screen and bombarded three times. Following bombardment, thetissue can be divided in half and placed back into liquid and culturedas described above.

Five to seven days post bombardment, the liquid media may be exchangedwith fresh media and eleven to twelve days post-bombardment with freshmedia containing 50 mg/ml hygromycin. This selective media can berefreshed weekly. Seven to eight weeks post-bombardment, green,transformed tissue may be observed growing from untransformed, necroticembryogenic clusters. Isolated green tissue is removed and inoculatedinto individual flasks to generate new, clonally propagated, transformedembryogenic suspension cultures. Each new line may be treated as anindependent transformation event. These suspensions can then besubcultured and maintained as clusters of immature embryos orregenerated into whole plants by maturation and germination ofindividual somatic embryos.

Example 7 Sunflower Meristem Tissue Transformation

Sunflower meristem tissues are transformed with an expression cassettecontaining an antisense NUE sequences operably linked to a ubiquitinpromoter as follows (see also, EP Patent Number 0 486233, hereinincorporated by reference and Malone-Schoneberg, et al., (1994) PlantScience 103:199-207). Mature sunflower seed (Helianthus annuus L.) aredehulled using a single wheat-head thresher. Seeds are surfacesterilized for 30 minutes in a 20% Clorox® bleach solution with theaddition of two drops of Tween® 20 per 50 ml of solution. The seeds arerinsed twice with sterile distilled water.

Split embryonic axis explants are prepared by a modification ofprocedures described by Schrammeijer, et al., (Schrammeijer, et al.,(1990) Plant Cell Rep. 9:55-60). Seeds are imbibed in distilled waterfor 60 minutes following the surface sterilization procedure. Thecotyledons of each seed are then broken off, producing a clean fractureat the plane of the embryonic axis. Following excision of the root tip,the explants are bisected longitudinally between the primordial leaves.The two halves are placed, cut surface up, on GBA medium consisting ofMurashige and Skoog mineral elements (Murashige, et al., (1962) Physiol.Plant., 15:473-497), Shepard's vitamin additions (Shepard, (1980) inEmergent Techniques for the Genetic Improvement of Crops (University ofMinnesota Press, St. Paul, Minn.), 40 mg/l adenine sulfate, 30 g/lsucrose, 0.5 mg/l 6-benzyl-aminopurine (BAP), 0.25 mg/l indole-3-aceticacid (IAA), 0.1 mg/l gibberellic acid (GA₃), pH 5.6 and 8 g/l Phytagar.

The explants are subjected to microprojectile bombardment prior toAgrobacterium treatment (Bidney, et al., (1992) Plant Mol. Biol.18:301-313). Thirty to forty explants are placed in a circle at thecenter of a 60×20 mm plate for this treatment. Approximately 4.7 mg of1.8 mm tungsten microprojectiles are resuspended in 25 ml of sterile TEbuffer (10 mM Tris HCl, 1 mM EDTA, pH 8.0) and 1.5 ml aliquots are usedper bombardment. Each plate is bombarded twice through a 150 mm nytexscreen placed 2 cm above the samples in a PDS 1000 particle accelerationdevice.

Disarmed Agrobacterium tumefaciens strain EHA105 is used in alltransformation experiments. A binary plasmid vector comprising theexpression cassette that contains the NUE gene operably linked to theubiquitin promoter is introduced into Agrobacterium strain EHA105 viafreeze-thawing as described by Holsters, et al., (1978) Mol. Gen. Genet.163:181-187. This plasmid further comprises a kanamycin selectablemarker gene (i.e, nptII). Bacteria for plant transformation experimentsare grown overnight (28° C. and 100 RPM continuous agitation) in liquidYEP medium (10 gm/l yeast extract, 10 gm/l Bacto® peptone and 5 gm/lNaCl, pH 7.0) with the appropriate antibiotics required for bacterialstrain and binary plasmid maintenance. The suspension is used when itreaches an OD₆₀₀ of about 0.4 to 0.8. The Agrobacterium cells arepelleted and resuspended at a final OD₆₀₀ of 0.5 in an inoculationmedium comprised of 12.5 mM MES pH 5.7, 1 gm/l NH₄Cl and 0.3 gm/l MgSO₄.

Freshly bombarded explants are placed in an Agrobacterium suspension,mixed and left undisturbed for 30 minutes. The explants are thentransferred to GBA medium and co-cultivated, cut surface down, at 26° C.and 18-hour days. After three days of co-cultivation, the explants aretransferred to 374B (GBA medium lacking growth regulators and a reducedsucrose level of 1%) supplemented with 250 mg/l cefotaxime and 50 mg/lkanamycin sulfate. The explants are cultured for two to five weeks onselection and then transferred to fresh 374B medium lacking kanamycinfor one to two weeks of continued development. Explants withdifferentiating, antibiotic-resistant areas of growth that have notproduced shoots suitable for excision are transferred to GBA mediumcontaining 250 mg/l cefotaxime for a second 3-day phytohormonetreatment. Leaf samples from green, kanamycin-resistant shoots areassayed for the presence of NPTII by ELISA and for the presence oftransgene expression by assaying for a modulation in meristemdevelopment (i.e., an alteration of size and appearance of shoot andfloral meristems).

NPTII-positive shoots are grafted to Pioneer® hybrid 6440 in vitro-grownsunflower seedling rootstock. Surface sterilized seeds are germinated in48-0 medium (half-strength Murashige and Skoog salts, 0.5% sucrose, 0.3%Gelrite®, pH 5.6) and grown under conditions described for explantculture. The upper portion of the seedling is removed, a 1 cm verticalslice is made in the hypocotyl and the transformed shoot inserted intothe cut. The entire area is wrapped with Parafilm® to secure the shoot.Grafted plants can be transferred to soil following one week of in vitroculture. Grafts in soil are maintained under high humidity conditionsfollowed by a slow acclimatization to the greenhouse environment.Transformed sectors of T₀ plants (parental generation) maturing in thegreenhouse are identified by NPTII ELISA and/or by NUE activity analysisof leaf extracts while transgenic seeds harvested from NPTII-positive T₀plants are identified by NUE activity analysis of small portions of dryseed cotyledon.

An alternative sunflower transformation protocol allows the recovery oftransgenic progeny without the use of chemical selection pressure. Seedsare dehulled and surface-sterilized for 20 minutes in a 20% Clorox®bleach solution with the addition of two to three drops of Tween® 20 per100 ml of solution, then rinsed three times with distilled water.Sterilized seeds are imbibed in the dark at 26° C. for 20 hours onfilter paper moistened with water. The cotyledons and root radical areremoved, and the meristem explants are cultured on 374E (GBA mediumconsisting of MS salts, Shepard vitamins, 40 mg/l adenine sulfate, 3%sucrose, 0.5 mg/l 6-BAP, 0.25 mg/l IAA, 0.1 mg/l GA and 0.8% Phytagar atpH 5.6) for 24 hours under the dark. The primary leaves are removed toexpose the apical meristem, around 40 explants are placed with theapical dome facing upward in a 2 cm circle in the center of 374M (GBAmedium with 1.2% Phytagar) and then cultured on the medium for 24 hoursin the dark.

Approximately 18.8 mg of 1.8 μm tungsten particles are resuspended in150 μl absolute ethanol. After sonication, 8 μl of it is dropped on thecenter of the surface of macrocarrier. Each plate is bombarded twicewith 650 psi rupture discs in the first shelf at 26 mm of Hg helium gunvacuum.

The plasmid of interest is introduced into Agrobacterium tumefaciensstrain EHA105 via freeze thawing as described previously. The pellet ofovernight-grown bacteria at 28° C. in a liquid YEP medium (10 g/l yeastextract, 10 g/l Bacto® peptone and 5 g/l NaCl, pH 7.0) in the presenceof 50 μg/l kanamycin is resuspended in an inoculation medium (12.5 mM2-mM 2-(N-morpholino) ethanesulfonic acid, MES, 1 g/l NH₄Cl and 0.3 g/lMgSO₄ at pH 5.7) to reach a final concentration of 4.0 at OD₆₀₀.Particle-bombarded explants are transferred to GBA medium (374E) and adroplet of bacteria suspension is placed directly onto the top of themeristem. The explants are co-cultivated on the medium for 4 days, afterwhich the explants are transferred to 374C medium (GBA with 1% sucroseand no BAP, IAA, GA3 and supplemented with 250 μg/ml cefotaxime). Theplantlets are cultured on the medium for about two weeks under 16-hourday and 26° C. incubation conditions.

Explants (around 2 cm long) from two weeks of culture in 374C medium arescreened for a modulation in meristem development (i.e., an alterationof size and appearance of shoot and floral meristems). After positiveexplants are identified, those shoots that fail to exhibit modified NUEactivity are discarded, and every positive explant is subdivided intonodal explants. One nodal explant contains at least one potential node.The nodal segments are cultured on GBA medium for three to four days topromote the formation of auxiliary buds from each node. Then they aretransferred to 374C medium and allowed to develop for an additional fourweeks. Developing buds are separated and cultured for an additional fourweeks on 374C medium. Pooled leaf samples from each newly recoveredshoot are screened again by the appropriate protein activity assay. Atthis time, the positive shoots recovered from a single node willgenerally have been enriched in the transgenic sector detected in theinitial assay prior to nodal culture.

Recovered shoots positive for modified NUE expression are grafted toPioneer® hybrid 6440 in vitro-grown sunflower seedling rootstock. Therootstocks are prepared in the following manner. Seeds are dehulled andsurface-sterilized for 20 minutes in a 20% Clorox® bleach solution withthe addition of two to three drops of Tween® 20 per 100 ml of solution,and are rinsed three times with distilled water. The sterilized seedsare germinated on the filter moistened with water for three days, thenthey are transferred into 48 medium (half-strength MS salt, 0.5%sucrose, 0.3% Gelrite® pH 5.0) and grown at 26° C. under the dark forthree days, then incubated at 16-hour-day culture conditions. The upperportion of selected seedling is removed, a vertical slice is made ineach hypocotyl and a transformed shoot is inserted into a V-cut. The cutarea is wrapped with Parafilm®. After one week of culture on the medium,grafted plants are transferred to soil. In the first two weeks, they aremaintained under high humidity conditions to acclimatize to a greenhouseenvironment.

Example 8 Rice Tissue Transformation Genetic Confirmation of the NUEGene

One method for transforming DNA into cells of higher plants that isavailable to those skilled in the art is high-velocity ballisticbombardment using metal particles coated with the nucleic acidconstructs of interest (see, Klein, et al., Nature (1987) (London)327:70-73 and see, U.S. Pat. No. 4,945,050). A Biolistic PDS-1000/He(BioRAD Laboratories, Hercules, Calif.) is used for thesecomplementation experiments. The particle bombardment technique is usedto transform the NUE mutants and wild type rice with DNA fragments

The bacterial hygromycin B phosphotransferase (Hpt II) gene fromStreptomyces hygroscopicus that confers resistance to the antibiotic isused as the selectable marker for rice transformation. In the vector,pML18, the Hpt II gene was engineered with the 35S promoter fromCauliflower Mosaic Virus and the termination and polyadenylation signalsfrom the octopine synthase gene of Agrobacterium tumefaciens. pML18 wasdescribed in WO 1997/47731, which was published on Dec. 18, 1997, thedisclosure of which is hereby incorporated by reference.

Embryogenic callus cultures derived from the scutellum of germinatingrice seeds serve as source material for transformation experiments. Thismaterial is generated by germinating sterile rice seeds on a callusinitiation media (MS salts, Nitsch and Nitsch vitamins, 1.0 mg/l 2,4-Dand 10 λM AgNO₃) in the dark at 27-28° C. Embryogenic callusproliferating from the scutellum of the embryos is the transferred to CMmedia (N6 salts, Nitsch and Nitsch vitamins, 1 mg/l 2,4-D, Chu, et al.,1985, Sci. Sinica 18:659-668). Callus cultures are maintained on CM byroutine sub-culture at two week intervals and used for transformationwithin 10 weeks of initiation.

Callus is prepared for transformation by subculturing 0.5-1.0 mm piecesapproximately 1 mm apart, arranged in a circular area of about 4 cm indiameter, in the center of a circle of Whatman #541 paper placed on CMmedia. The plates with callus are incubated in the dark at 27-28° C. for3-5 days. Prior to bombardment, the filters with callus are transferredto CM supplemented with 0.25 M mannitol and 0.25 M sorbitol for 3 hr inthe dark. The petri dish lids are then left ajar for 20-45 minutes in asterile hood to allow moisture on tissue to dissipate.

Each genomic DNA fragment is co-precipitated with pML18 containing theselectable marker for rice transformation onto the surface of goldparticles. To accomplish this, a total of 10 μg of DNA at a 2:1 ratio oftrait:selectable marker DNAs are added to 50 μl aliquot of goldparticles that have been resuspended at a concentration of 60 mg ml⁻¹.Calcium chloride (50 μl of a 2.5 M solution) and spermidine (20 μl of a0.1 M solution) are then added to the gold-DNA suspension as the tube isvortexing for 3 min. The gold particles are centrifuged in a microfugefor 1 sec and the supernatant removed. The gold particles are thenwashed twice with 1 ml of absolute ethanol and then resuspended in 50 μlof absolute ethanol and sonicated (bath sonicator) for one second todisperse the gold particles. The gold suspension is incubated at −70° C.for five minutes and sonicated (bath sonicator) if needed to dispersethe particles. Six μl of the DNA-coated gold particles are then loadedonto mylar macrocarrier disks and the ethanol is allowed to evaporate.

At the end of the drying period, a petri dish containing the tissue isplaced in the chamber of the PDS-1000/He. The air in the chamber is thenevacuated to a vacuum of 28-29 inches Hg. The macrocarrier isaccelerated with a helium shock wave using a rupture membrane thatbursts when the He pressure in the shock tube reaches 1080-1100 psi. Thetissue is placed approximately 8 cm from the stopping screen and thecallus is bombarded two times. Two to four plates of tissue arebombarded in this way with the DNA-coated gold particles. Followingbombardment, the callus tissue is transferred to CM media withoutsupplemental sorbitol or mannitol.

Within 3-5 days after bombardment the callus tissue is transferred to SMmedia (CM medium containing 50 mg/l hygromycin). To accomplish this,callus tissue is transferred from plates to sterile 50 ml conical tubesand weighed. Molten top-agar at 40° C. is added using 2.5 ml of topagar/100 mg of callus. Callus clumps are broken into fragments of lessthan 2 mm diameter by repeated dispensing through a 10 ml pipet. Threeml aliquots of the callus suspension are plated onto fresh SM media andthe plates are incubated in the dark for 4 weeks at 27-28° C. After 4weeks, transgenic callus events are identified, transferred to fresh SMplates and grown for an additional 2 weeks in the dark at 27-28° C.

Growing callus is transferred to RM1 media (MS salts, Nitsch and Nitschvitamins, 2% sucrose, 3% sorbitol, 0.4% Gelrite®+50 ppm hyg B) for 2weeks in the dark at 25° C. After 2 weeks the callus is transferred toRM2 media (MS salts, Nitsch and Nitsch vitamins, 3% sucrose, 0.4%Gelrite®+50 ppm hyg B) and placed under cool white light (˜40 μEm⁻²s⁻¹)with a 12 hr photoperiod at 25° C. and 30-40% humidity. After 2-4 weeksin the light, callus begin to organize and form shoots. Shoots areremoved from surrounding callus/media and gently transferred to RM3media (½×MS salts, Nitsch and Nitsch vitamins, 1% sucrose+50 ppmhygromycin B) in phytatrays (Sigma Chemical Co., St. Louis, Mo.) andincubation is continued using the same conditions as described in theprevious step.

Plants are transferred from RM3 to 4″ pots containing Metro mix 350after 2-3 weeks, when sufficient root and shoot growth have occurred.The seed obtained from the transgenic plants is examined for geneticcomplementation of the NUE mutation with the wild-type genomic DNAcontaining the NUE gene.

Example 9 Variants of NUE Sequences

A. Variant Nucleotide Sequences of NUE that do not Alter the EncodedAmino Acid Sequence

The NUE nucleotide sequences are used to generate variant nucleotidesequences having the nucleotide sequence of the open reading frame withabout 70%, 75%, 80%, 85%, 90% and 95% nucleotide sequence identity whencompared to the starting unaltered ORF nucleotide sequence of thecorresponding SEQ ID NO. These functional variants are generated using astandard codon table. While the nucleotide sequence of the variants arealtered, the amino acid sequence encoded by the open reading frames donot change.

B. Variant Amino Acid Sequences of NUE Polypeptides

Variant amino acid sequences of the NUE polypeptides are generated. Inthis example, one amino acid is altered. Specifically, the open readingframes are reviewed to determine the appropriate amino acid alteration.The selection of the amino acid to change is made by consulting theprotein alignment (with the other orthologs and other gene familymembers from various species). An amino acid is selected that is deemednot to be under high selection pressure (not highly conserved) and whichis rather easily substituted by an amino acid with similar chemicalcharacteristics (i.e., similar functional side-chain). Using the proteinalignment, an appropriate amino acid can be changed. Once the targetedamino acid is identified, the procedure outlined in the followingsection C is followed. Variants having about 70%, 75%, 80%, 85%, 90% and95% nucleic acid sequence identity are generated using this method.

C. Additional Variant Amino Acid Sequences of NUE Polypeptides

In this example, artificial protein sequences are created having 80%,85%, 90% and 95% identity relative to the reference protein sequence.This latter effort requires identifying conserved and variable regionsfrom the alignment and then the judicious application of an amino acidsubstitutions table. These parts will be discussed in more detail below.

Largely, the determination of which amino acid sequences are altered ismade based on the conserved regions among NUE protein or among the otherNUE polypeptides. Based on the sequence alignment, the various regionsof the NUE polypeptide that can likely be altered are represented inlower case letters, while the conserved regions are represented bycapital letters. It is recognized that conservative substitutions can bemade in the conserved regions below without altering function. Inaddition, one of skill will understand that functional variants of theNUE sequence of the invention can have minor non-conserved amino acidalterations in the conserved domain.

Artificial protein sequences are then created that are different fromthe original in the intervals of 80-85%, 85-90%, 90-95% and 95-100%identity. Midpoints of these intervals are targeted, with liberallatitude of plus or minus 1%, for example. The amino acids substitutionswill be effected by a custom Perl script. The substitution table isprovided below in Table 2.

TABLE 2 Substitution Table Rank of Strongly Similar and Order to AminoAcid Optimal Substitution Change Comment I L, V 1 50:50 substitution LI, V 2 50:50 substitution V I, L 3 50:50 substitution A G 4 G A 5 D E 6E D 7 W Y 8 Y W 9 S T 10 T S 11 K R 12 R K 13 N Q 14 Q N 15 F Y 16 M L17 First methionine cannot change H Na No good substitutes C Na No goodsubstitutes P Na No good substitutes

First, any conserved amino acids in the protein that should not bechanged is identified and “marked off” for insulation from thesubstitution. The start methionine will of course be added to this listautomatically. Next, the changes are made.

H, C and P are not changed in any circumstance. The changes will occurwith isoleucine first, sweeping N-terminal to C-terminal. Then leucineand so on down the list until the desired target it reached. Interimnumber substitutions can be made so as not to cause reversal of changes.The list is ordered 1-17, so start with as many isoleucine changes asneeded before leucine, and so on down to methionine. Clearly many aminoacids will in this manner not need to be changed. L, I and V willinvolve a 50:50 substitution of the two alternate optimal substitutions.

The variant amino acid sequences are written as output. Perl script isused to calculate the percent identities. Using this procedure, variantsof the NUE polypeptides are generating having about 80%, 85%, 90% and95% amino acid identity to the starting unaltered ORF is nucleotidesequence of SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25,27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61,63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97,99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125,127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153,155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181,183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209,211, 213, 215, 217, 219, 221, 223, 225, 227, 229, 231, 233, 235, 237,239, 241, 243, 245, 247, 249, 251, 253, 255, 257, 259, 261, 263, 265,267, 269, 271, 273, 275, 277, 279, 281, 283, 285, 287, 289, 291, 293,295, 297, 299, 301, 303, 305, 307, 309, 311 or 313.

Example 10 Transgenic Maize Plants

T₀ transgenic maize plants containing the NUE construct under thecontrol of a promoter were generated. These plants were grown ingreenhouse conditions, under the FASTCORN system, as detailed in USPatent Application Publication Number 2003/0221212, U.S. patentapplication Ser. No. 10/367,417.

Each of the plants was analyzed for measurable alteration in one or moreof the following characteristics in the following manner:

T₁ progeny derived from self fertilization each T₀ plant containing asingle copy of each NUE construct that were found to segregate 1:1 forthe transgenic event were analyzed for improved growth rate in low KNO₃.Growth was monitored up to anthesis when cumulative plant growth, growthrate and ear weight were determined for transgene positive, transgenenull, and non-transformed controls events. The distribution of thephenotype of individual plants was compared to the distribution of acontrol set and to the distribution of all the remaining treatments.Variances for each set were calculated and compared using an F test,comparing the event variance to a non-transgenic control set varianceand to the pooled variance of the remaining events in the experiment.The greater the response to KNO₃, the greater the variance within anevent set and the greater the F value. Positive results will be comparedto the distribution of the transgene within the event to make sure theresponse segregates with the transgene.

Example 11 Transgenic Event Analysis from Field Plots

Transgenic events are evaluated in field plots where yield is limited byreducing fertilizer application by 30% or more. Improvements in yield,yield components or other agronomic traits between transgenic andnon-transgenic plants in these reduced nitrogen fertility plots are usedto assess improvements in nitrogen utilization contributed by expressionof transgenic events. Similar comparisons are made in plots supplementedwith recommended nitrogen fertility rates. Effective transgenic eventsare those that achieve similar yields in the nitrogen-limited and normalnitrogen experiments.

All publications and patent applications in this specification areindicative of the level of ordinary skill in the art to which thisinvention pertains. All publications and patent applications are hereinincorporated by reference to the same extent as if each individualpublication or patent application was specifically and individuallyindicated by reference.

The invention has been described with reference to various specific andpreferred embodiments and techniques. However, it should be understoodthat many variations and modifications may be made while remainingwithin the spirit and scope of the invention

What is claimed is:
 1. An isolated polynucleotide selected from thegroup consisting of: a. a polynucleotide having at least 70% sequenceidentity, as determined by the GAP algorithm under default parameters,to the full length sequence of a polynucleotide selected from the groupconsisting of SEQ ID NOS: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25,27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61,63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97,99, 101, 103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125,127, 129, 131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153,155, 157, 159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181,183, 185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209,211, 213, 215, 217, 219, 221, 223, 225, 227, 229, 231, 233, 235, 237,239, 241, 243, 245, 247, 249, 251, 253, 255, 257, 259, 261, 263, 265,267, 269, 271, 273, 275, 277, 279, 281, 283, 285, 287, 289, 291, 293,295, 297, 299, 301, 303, 305, 307, 309, 311 and 313; wherein thepolynucleotide encodes a polypeptide that functions as a modifier ofnitrogen utilization efficiency; b. a polynucleotide encoding apolypeptide selected from the group consisting of SEQ ID NO: 2, 4, 6, 8,10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44,46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80,82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112,114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134, 136, 138, 140,142, 144, 146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168,170, 172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196,198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224,226, 228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252,254, 256, 258, 260, 262, 264, 266, 268, 270, 272, 274, 276, 278, 280,282, 284, 286, 288, 290, 292, 294, 296, 298, 300, 302, 304, 306, 308,310, 312 and 314; c. a polynucleotide selected from the group consistingof SEQ ID NOS: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29,31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65,67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101,103, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129,131, 133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157,159, 161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185,187, 189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213,215, 217, 219, 221, 223, 225, 227, 229, 231, 233, 235, 237, 239, 241,243, 245, 247, 249, 251, 253, 255, 257, 259, 261, 263, 265, 267, 269,271, 273, 275, 277, 279, 281, 283, 285, 287, 289, 291, 293, 295, 297,299, 301, 303, 305, 307, 309, 311 and 313; and d. A polynucleotide whichis complementary to the polynucleotide of (a), (b) or (c).
 2. Arecombinant expression cassette, comprising the polynucleotide of claim1, wherein the polynucleotide is operably linked, in sense or anti-senseorientation, to a promoter.
 3. A host cell comprising the expressioncassette of claim
 2. 4. A transgenic plant comprising the recombinantexpression cassette of claim
 2. 5. The transgenic plant of claim 4,wherein said plant is a monocot.
 6. The transgenic plant of claim 4,wherein said plant is a dicot.
 7. The transgenic plant of claim 4,wherein said plant is selected from the group consisting of: maize,soybean, sunflower, sorghum, canola, wheat, alfalfa, cotton, rice,barley, millet, peanut and cocoa.
 8. A transgenic seed from thetransgenic plant of claim
 4. 9. A method of modulating nitrogenutilization efficiency in plants, comprising: a. introducing into aplant cell a recombinant expression cassette comprising thepolynucleotide of claim 1 operably linked to a promoter; and b.culturing the plant under plant cell growing conditions; wherein thenitrogen utilization in said plant cell is modulated.
 10. The method ofclaim 9, wherein the plant cell is from a plant selected from the groupconsisting of: maize, soybean, sunflower, sorghum, canola, wheat,alfalfa, cotton, rice, barley, millet, peanut and cocoa.
 11. A method ofmodulating the nitrogen utilization efficiency in a plant, comprising:a. introducing into a plant cell a recombinant expression cassettecomprising the polynucleotide of claim 1 operably linked to a promoter;b. culturing the plant cell under plant cell growing conditions; and c.regenerating a plant form said plant cell; wherein the nitrogenutilization efficiency in said plant is modulated.
 12. The method ofclaim 11, wherein the plant is selected from the group consisting of:maize, soybean, sorghum, canola, wheat, alfalfa, cotton, rice, barley,millet, peanut and cocoa.
 13. A method of decreasing the NUE polypeptideactivity in a plant cell, comprising: a. providing a nucleotide sequencecomprising at least 15 consecutive nucleotides of the complement of SEQID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33,35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69,71, 73, 75, 77, 79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103,105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131,133, 135, 137, 139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159,161, 163, 165, 167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187,189, 191, 193, 195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215,217, 219, 221, 223, 225, 227, 229, 231, 233, 235, 237, 239, 241, 243,245, 247, 249, 251, 253, 255, 257, 259, 261, 263, 265, 267, 269, 271,273, 275, 277, 279, 281, 283, 285, 287, 289, 291, 293, 295, 297, 299,301, 303, 305, 307, 309, 311 or 313; b. providing a plant cellcomprising an mRNA having the sequence set forth in SEQ ID NO: 1, 3, 5,7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41,43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77,79, 81, 83, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107, 109,111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133, 135, 137,139, 141, 143, 145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165,167, 169, 171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193,195, 197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221,223, 225, 227, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249,251, 253, 255, 257, 259, 261, 263, 265, 267, 269, 271, 273, 275, 277,279, 281, 283, 285, 287, 289, 291, 293, 295, 297, 299, 301, 303, 305,307, 309, 311 or 313; and c. introducing the nucleotide sequence of step(a) into the plant cell of step (b), wherein the nucleotide sequenceinhibits expression of the mRNA in the plant cell.
 14. The method ofclaim 13, wherein said plant cell is from a monocot.
 15. The method ofclaim 14, wherein said monocot is maize, wheat, rice, barley, sorghum orrye.
 16. The method of claim 13, wherein said plant cell is from adicot.
 17. The transgenic plant of claim 4, wherein the nitrogenutilization efficiency activity in said plant is increased.
 18. Thetransgenic plant of claim 17, wherein the plant has enhanced rootgrowth.
 19. The transgenic plant of claim 17, wherein the plant hasincreased seed size.
 20. The transgenic plant of claim 17, wherein theplant has increased seed weight.
 21. The transgenic plant of claim 17,wherein the plant has seed with increased embryo size.
 22. Thetransgenic plant of claim 17, wherein the plant has increased leaf size.23. The transgenic plant of claim 17, wherein the plant has increasedseedling vigor.
 24. The transgenic plant of claim 17, wherein the planthas enhanced silk emergence.
 25. The transgenic plant of claim 17,wherein the plant has increased ear size.
 26. The transgenic plant ofclaim 4, wherein the nitrogen utilization efficiency activity in saidplant is decreased.
 27. The transgenic plant of claim 26, wherein theplant has decreased root growth.
 28. The transgenic plant of claim 26,wherein the plant has decreased seed size.
 29. The transgenic plant ofclaim 26, wherein the plant has decreased seed weight.
 30. Thetransgenic plant of claim 26, wherein the plant has decreased embryosize.
 31. The transgenic plant of claim 26, wherein the plant hasdecreased tassel production.